2f:I[703058,["/_next/static/immutable/chunks/3bhq_5eh1d760.js","/_next/static/immutable/chunks/2iy5wruuedsh6.js","/_next/static/immutable/chunks/2pfsjpn6k6zlg.js","/_next/static/immutable/chunks/26c7v3_3uwnwu.js","/_next/static/immutable/chunks/00yc7rcvua6a7.js","/_next/static/immutable/chunks/37ktb71aq3480.js","/_next/static/immutable/chunks/2d50b-7eu4558.js","/_next/static/immutable/chunks/06_yt270h41rg.js","/_next/static/immutable/chunks/2d6noqpp6ehas.js","/_next/static/immutable/chunks/1sx186c93bpzg.js","/_next/static/immutable/chunks/3dc-1n866s65i.js","/_next/static/immutable/chunks/20x2y96ldu5wx.js","/_next/static/immutable/chunks/2w1bvggzb0ga8.js","/_next/static/immutable/chunks/2051ffx3xzio9.js"],"PaperListPageClient"] 30:T845,The fungal diagnostic landscape is evolving; whereas previously, traditional culture-based methods dominated, most invasive fungal disease is now diagnosed with non-culture-based tests, including direct microscopy, antigen, antibody, and molecular assays, supported by histopathology and radiology. Access to and turnaround time of diagnostic tests and their clinical implementation varies across the UK. The British Society for Medical Mycology convened an expert group to update its 2015 best practice guidance. Guidance on histopathology and radiology investigations remain unchanged from the 2015 standards of care. For each mycological test, we include test-specific commentaries and accompanying tables, with expected turnaround times (sample collection to reporting). Based on recent evidence, new or stronger recommendations include use of Pneumocystis PCR; 1,3-β-D-glucan testing for suspected invasive candidiasis and Pneumocystis pneumonia; higher volume respiratory sample cultures; Aspergillus antigen or antibody-based testing in expanded clinically vulnerable populations, including patients in intensive care units and patients with chronic respiratory disease (including asthma); use of Candida PCR and Mucorales PCR in specific contexts; pan-fungal PCR and DNA sequencing for fungal identification from positive microscopy or histopathology specimens; and inclusion of posaconazole and isavuconazole in therapeutic antifungal monitoring recommendations. We discuss integration of diagnostic tests with antifungal stewardship and common clinical scenarios. Although recommendations focus on adults and UK practice, use in paediatric populations and worldwide applicability is discussed. Recommendations are presented as auditable standards to facilitate implementation and quality improvement measures. An emphasis on integration of combined diagnostics with antifungal stewardship and clinical pathways extends guideline relevance beyond microbiology laboratories to clinicians investigating patients with multimorbidity and suspected fungal disease within increasingly complex health-care systems.31:T49a,The search yielded 96 studies (1954-2025) documenting 134 patients. The number of reports has notably increased since the 21st century; however, diagnosis remains challenging due to possible dermatophyte adaptation in the dermal/subcutaneous environment. Trichophyton rubrum is the most frequently isolated pathogen. Acquired immunodeficiencies (e.g. renal transplant recipients) and primary immunodeficiencies (e.g. CARD9, STAT3 mutations) elevate the risk of deep dermatophytosis. Systemic dissemination, often accompanied by lymphadenopathy, was reported in 24 patients, with the most common being infection of the axillary and inguinal lymph nodes. Infections of the bones, lungs, and brain were also reported. Terbinafine (125-1000 mg/day) and itraconazole (100-400 mg/day), with adjunctive topical antifungals and surgical interventions, have been tried for deep dermatophytosis. The use of newer triazoles (voriconazole, posaconazole) should follow the principles of antifungal stewardship and therapeutic drug monitoring recommendations. Multidrug resistance is a potential concern in immunocompromised patients who will often require extended or lifelong treatment.32:T89b,Dermatophytes-a group of obligate keratinophilic fungi that infect the skin, hair and nails-represent the most common cause of fungal infections worldwide. In immunocompromised individuals, a growing body of literature has documented rare instances of dermatophyte infections of the dermis and subcutaneous tissue, which can lead to deep dermatophytosis with systemic dissemination and pseudomycetoma as secondary complications. To assess patient characteristics, risk factors, diagnostic evidence and treatment options for deep dermatophytosis. A systematic review was conducted in June 2025 to identify patients presenting with deep dermatophytosis of the glabrous skin; all cases were validated by confirmatory testing per histopathologic examination and fungal culture. Majocchi's granuloma diagnoses were excluded. The search yielded 96 studies (1954-2025) documenting 134 patients. The number of reports has notably increased since the 21st century; however, diagnosis remains challenging due to possible dermatophyte adaptation in the dermal/subcutaneous environment. Trichophyton rubrum is the most frequently isolated pathogen. Acquired immunodeficiencies (e.g. renal transplant recipients) and primary immunodeficiencies (e.g. CARD9, STAT3 mutations) elevate the risk of deep dermatophytosis. Systemic dissemination, often accompanied by lymphadenopathy, was reported in 24 patients, with the most common being infection of the axillary and inguinal lymph nodes. Infections of the bones, lungs, and brain were also reported. Terbinafine (125-1000 mg/day) and itraconazole (100-400 mg/day), with adjunctive topical antifungals and surgical interventions, have been tried for deep dermatophytosis. The use of newer triazoles (voriconazole, posaconazole) should follow the principles of antifungal stewardship and therapeutic drug monitoring recommendations. Multidrug resistance is a potential concern in immunocompromised patients who will often require extended or lifelong treatment. Healthcare providers should be cognizant that dermatophytosis may become invasive and disseminated in immunocompromised populations. Testing and early treatment should not be overlooked in these patients.33:Ta45,AbstractBackgroundDermatophytes—a group of obligate keratinophilic fungi that infect the skin, hair and nails—represent the most common cause of fungal infections worldwide. In immunocompromised individuals, a growing body of literature has documented rare instances of dermatophyte infections of the dermis and subcutaneous tissue, which can lead to deep dermatophytosis with systemic dissemination and pseudomycetoma as secondary complications.ObjectivesTo assess patient characteristics, risk factors, diagnostic evidence and treatment options for deep dermatophytosis.MethodsA systematic review was conducted in June 2025 to identify patients presenting with deep dermatophytosis of the glabrous skin; all cases were validated by confirmatory testing per histopathologic examination and fungal culture. Majocchi's granuloma diagnoses were excluded.ResultsThe search yielded 96 studies (1954–2025) documenting 134 patients. The number of reports has notably increased since the 21st century; however, diagnosis remains challenging due to possible dermatophyte adaptation in the dermal/subcutaneous environment. Trichophyton rubrum is the most frequently isolated pathogen. Acquired immunodeficiencies (e.g. renal transplant recipients) and primary immunodeficiencies (e.g. CARD9, STAT3 mutations) elevate the risk of deep dermatophytosis. Systemic dissemination, often accompanied by lymphadenopathy, was reported in 24 patients, with the most common being infection of the axillary and inguinal lymph nodes. Infections of the bones, lungs, and brain were also reported. Terbinafine (125–1000 mg/day) and itraconazole (100–400 mg/day), with adjunctive topical antifungals and surgical interventions, have been tried for deep dermatophytosis. The use of newer triazoles (voriconazole, posaconazole) should follow the principles of antifungal stewardship and therapeutic drug monitoring recommendations. Multidrug resistance is a potential concern in immunocompromised patients who will often require extended or lifelong treatment.ConclusionsHealthcare providers should be cognizant that dermatophytosis may become invasive and disseminated in immunocompromised populations. Testing and early treatment should not be overlooked in these patients.25:[[["$","script","0",{"type":"application/ld+json","dangerouslySetInnerHTML":{"__html":"{\"@context\":\"https://schema.org\",\"@type\":\"CollectionPage\",\"name\":\"posaconazole: generic Research & Clinical Takeaways\",\"description\":\"Explore peer-reviewed papers on posaconazole (generic). Clinician-written summaries and actionable practice insights. Updated daily.\",\"url\":\"https://www.reachrx.ai/hub/tag/generic/posaconazole\",\"breadcrumb\":{\"@type\":\"BreadcrumbList\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https://www.reachrx.ai\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Research Hub\",\"item\":\"https://www.reachrx.ai/hub\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Generics\",\"item\":\"https://www.reachrx.ai/hub/tag/generic\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"posaconazole\",\"item\":\"https://www.reachrx.ai/hub/tag/generic/posaconazole\"}]}}"}}]],["$","$L2f",null,{"title":"posaconazole: Research & Clinical Takeaways","description":"Explore research on posaconazole (generic) — efficacy, safety, and comparative data.","papers":[{"doi":"10.1016/j.jgar.2026.08.012","pmid":"42600985","title":"Clinical positioning of Voriconazole, Posaconazole, and Isavuconazole in the treatment of Invasive Pulmonary Aspergillosis: A Global Real-World Database Study","journal_title":"Journal of Global Antimicrobial Resistance","journal_issn":"2213-7165","published_at":"2026-08-14T00:00:00.000Z","url":"https://doi.org/10.1016/j.jgar.2026.08.012","source_score":15,"is_retracted":false,"is_open_access":true,"raw_metadata":{"pubmed":true,"crossref":true,"unpaywall":true},"created_at":"2026-08-17T13:33:12.701Z","updated_at":"2026-08-17T13:33:12.701Z","tags":[{"paper_doi":"10.1016/j.jgar.2026.08.012","tag_type":"age_group","value":"adult","value_numeric":null},{"paper_doi":"10.1016/j.jgar.2026.08.012","tag_type":"category","value":"Infectious Diseases","value_numeric":null},{"paper_doi":"10.1016/j.jgar.2026.08.012","tag_type":"condition","value":"Invasive Pulmonary Aspergillosis","value_numeric":null},{"paper_doi":"10.1016/j.jgar.2026.08.012","tag_type":"generic","value":"isavuconazole","value_numeric":null},{"paper_doi":"10.1016/j.jgar.2026.08.012","tag_type":"generic","value":"posaconazole","value_numeric":null},{"paper_doi":"10.1016/j.jgar.2026.08.012","tag_type":"generic","value":"voriconazole","value_numeric":null},{"paper_doi":"10.1016/j.jgar.2026.08.012","tag_type":"impact_flag","value":"confirms_prior","value_numeric":null},{"paper_doi":"10.1016/j.jgar.2026.08.012","tag_type":"level_of_evidence","value":"3","value_numeric":null},{"paper_doi":"10.1016/j.jgar.2026.08.012","tag_type":"modality","value":"Antifungal Triazole","value_numeric":null},{"paper_doi":"10.1016/j.jgar.2026.08.012","tag_type":"sample_size","value":"n=3603","value_numeric":3603},{"paper_doi":"10.1016/j.jgar.2026.08.012","tag_type":"sex","value":"mixed","value_numeric":null},{"paper_doi":"10.1016/j.jgar.2026.08.012","tag_type":"study_design","value":"Retrospective Cohort Study","value_numeric":null},{"paper_doi":"10.1016/j.jgar.2026.08.012","tag_type":"warning","value":"Age group is not explicitly reported in the abstract; 'adult' is inferred from the clinical context of IPA management and TriNetX database characteristics.","value_numeric":null},{"paper_doi":"10.1016/j.jgar.2026.08.012","tag_type":"warning","value":"PSCZ and ISCZ were combined into a single comparator group; head-to-head differences between posaconazole and isavuconazole cannot be assessed from this study.","value_numeric":null},{"paper_doi":"10.1016/j.jgar.2026.08.012","tag_type":"warning","value":"The paper was published August 14, 2026 — just 3 days before today's date — and may not yet have undergone full post-publication review or citation scrutiny.","value_numeric":null}],"summaries":{"what_studied":"This retrospective real-world study used the TriNetX database (2010–2025) to compare 6-week all-cause mortality in adults with invasive pulmonary aspergillosis (IPA) treated with voriconazole (VRCZ) vs. posaconazole or isavuconazole (PSCZ/ISCZ), with propensity score matching (PSM) applied to balance 738 pairs.","key_result":"6-week all-cause mortality was 18.6% with VRCZ vs. 16.4% with PSCZ/ISCZ (OR 1.16; 95% CI 0.89–1.52; p=0.273) — a non-significant difference that held across subgroup and sensitivity analyses, even though PSCZ/ISCZ patients had higher baseline severity and more renal impairment before matching.","limitations":"- Retrospective database design limits causal inference and may have residual confounding despite PSM.\n- PSCZ and ISCZ were pooled together, masking potential outcome differences between those two agents.\n- TriNetX data rely on administrative coding, which may misclassify IPA diagnosis or treatment intent.","practice_takeaway":"For patients with IPA who cannot tolerate voriconazole — especially those with renal impairment or higher baseline severity — posaconazole or isavuconazole appear to be viable alternatives with comparable mortality outcomes. Clinicians can use these agents in a personalized approach without expecting a mortality penalty in real-world settings."}},{"doi":"10.1016/s1473-3099(25)00550-x","pmid":"41232547","title":"British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases: 2025 update","journal_title":"The Lancet Infectious Diseases","journal_issn":"1473-3099","published_at":"2025-11-14T00:00:00.000Z","url":"https://doi.org/10.1016/s1473-3099(25)00550-x","source_score":112,"is_retracted":false,"is_open_access":false,"raw_metadata":{"ooir":{"day":"2025-12-02","doi":"10.1016/s1473-3099(25)00550-x","days":"30","issn":"1473-3099","rank":"4","field":"Clinical Medicine","score":"112","category":"Infectious Diseases","categories":["Infectious Diseases"],"_categories":["Infectious Diseases"]},"pubmed":{"doi":"10.1016/S1473-3099(25)00550-X","title":"British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases: 2025 update.","journal":"The Lancet. Infectious diseases","methods":"","results":"","abstract":"$30","keywords":[],"pubmed_id":"41232547","conclusions":"","publication_date":"2025-11-14T00:00:00"},"crossref":{"DOI":"10.1016/s1473-3099(25)00550-x","URL":"https://doi.org/10.1016/s1473-3099(25)00550-x","ISSN":["1473-3099"],"link":[{"URL":"https://api.elsevier.com/content/article/PII:S147330992500550X?httpAccept=text/xml","content-type":"text/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https://api.elsevier.com/content/article/PII:S147330992500550X?httpAccept=text/plain","content-type":"text/plain","content-version":"vor","intended-application":"text-mining"}],"page":null,"type":"journal-article","issue":null,"score":1,"title":["British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases: 2025 update"],"author":[{"given":"Silke","family":"Schelenz","sequence":"first","affiliation":[]},{"given":"Alireza","family":"Abdolrasouli","sequence":"additional","affiliation":[]},{"given":"Darius","family":"Armstrong-James","sequence":"additional","affiliation":[]},{"given":"H Ruth","family":"Ashbee","sequence":"additional","affiliation":[]},{"given":"Richard","family":"Barton","sequence":"additional","affiliation":[]},{"given":"Tihana","family":"Bicanic","sequence":"additional","affiliation":[]},{"given":"Andy","family":"Borman","sequence":"additional","affiliation":[]},{"given":"Lottie","family":"Brown","sequence":"additional","affiliation":[]},{"given":"Chris","family":"Eades","sequence":"additional","affiliation":[]},{"given":"Laura","family":"Ferreras-Antolin","sequence":"additional","affiliation":[]},{"given":"Rebecca","family":"Gorton","sequence":"additional","affiliation":[]},{"given":"Ronan","family":"McMullan","sequence":"additional","affiliation":[]},{"given":"Iain","family":"Page","sequence":"additional","affiliation":[]},{"given":"Nelun","family":"Perera","sequence":"additional","affiliation":[]},{"given":"Riina","family":"Rautemaa-Richardson","sequence":"additional","affiliation":[]},{"given":"Johannes","family":"Wagener","sequence":"additional","affiliation":[]},{"given":"P","family":"Lewis White","sequence":"additional","affiliation":[]},{"given":"David W","family":"Denning","sequence":"additional","affiliation":[]}],"issued":{"date-parts":[[2025,11]]},"member":"78","prefix":"10.1016","source":"Crossref","volume":null,"created":{"date-time":"2025-11-11T12:34:33Z","timestamp":1762864473000,"date-parts":[[2025,11,11]]},"indexed":{"date-time":"2025-11-21T23:04:50Z","timestamp":1763766290450,"date-parts":[[2025,11,21]]},"license":[{"URL":"https://www.elsevier.com/tdm/userlicense/1.0/","start":{"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000,"date-parts":[[2025,11,1]]},"delay-in-days":0,"content-version":"tdm"},{"URL":"https://www.elsevier.com/legal/tdmrep-license","start":{"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000,"date-parts":[[2025,11,1]]},"delay-in-days":0,"content-version":"tdm"},{"URL":"https://doi.org/10.15223/policy-017","start":{"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000,"date-parts":[[2025,11,1]]},"delay-in-days":0,"content-version":"stm-asf"},{"URL":"https://doi.org/10.15223/policy-037","start":{"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000,"date-parts":[[2025,11,1]]},"delay-in-days":0,"content-version":"stm-asf"},{"URL":"https://doi.org/10.15223/policy-012","start":{"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000,"date-parts":[[2025,11,1]]},"delay-in-days":0,"content-version":"stm-asf"},{"URL":"https://doi.org/10.15223/policy-029","start":{"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000,"date-parts":[[2025,11,1]]},"delay-in-days":0,"content-version":"stm-asf"},{"URL":"https://doi.org/10.15223/policy-004","start":{"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000,"date-parts":[[2025,11,1]]},"delay-in-days":0,"content-version":"stm-asf"}],"subject":[],"abstract":null,"language":"en","relation":{},"resource":{"primary":{"URL":"https://linkinghub.elsevier.com/retrieve/pii/S147330992500550X"}},"subtitle":[],"assertion":[{"name":"publisher","label":"This article is maintained by","value":"Elsevier"},{"name":"articletitle","label":"Article Title","value":"British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases: 2025 update"},{"name":"journaltitle","label":"Journal Title","value":"The Lancet Infectious Diseases"},{"name":"articlelink","label":"CrossRef DOI link to publisher maintained version","value":"https://doi.org/10.1016/S1473-3099(25)00550-X"},{"name":"content_type","label":"Content Type","value":"article"},{"name":"copyright","label":"Copyright","value":"© 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies."}],"deposited":{"date-time":"2025-11-21T22:55:08Z","timestamp":1763765708000,"date-parts":[[2025,11,21]]},"issn-type":[{"type":"print","value":"1473-3099"}],"published":{"date-parts":[[2025,11]]},"publisher":"Elsevier BV","reference":[{"DOI":"10.1016/S1473-3099(23)00692-8","key":"10.1016/S1473-3099(25)00550-X_bib1","year":"2024","issue":null,"author":"Denning","volume":"24","first-page":"e428","unstructured":null,"article-title":"Global incidence and mortality of severe fungal disease","journal-title":"Lancet Infect Dis","doi-asserted-by":"crossref"},{"DOI":"10.1016/S1473-3099(15)70006-X","key":"10.1016/S1473-3099(25)00550-X_bib2","year":"2015","issue":null,"author":"Schelenz","volume":"15","first-page":"461","unstructured":null,"article-title":"British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases","journal-title":"Lancet Infect Dis","doi-asserted-by":"crossref"},{"DOI":"10.1093/mmy/myac081","key":"10.1016/S1473-3099(25)00550-X_bib3","year":"2022","issue":null,"author":"Borman","volume":"60","first-page":null,"unstructured":null,"article-title":"The importance of appropriate processing and direct microscopic examination for the timely diagnosis and management of invasive infections caused by filamentous fungi","journal-title":"Med Mycol","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.cmi.2023.05.012","key":"10.1016/S1473-3099(25)00550-X_bib4","year":"2023","issue":null,"author":"Knoll","volume":"29","first-page":"1031","unstructured":null,"article-title":"How to use direct microscopy for diagnosing fungal infections","journal-title":"Clin Microbiol Infect","doi-asserted-by":"crossref"},{"DOI":null,"key":"10.1016/S1473-3099(25)00550-X_bib5","year":"2021","issue":null,"author":"Wengenack","volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"10.1016/S1473-3099(25)00550-X_bib6","year":"2021","issue":null,"author":"Abdolrasouli","volume":null,"first-page":null,"unstructured":null,"article-title":"Processing specimens for fungal culture","journal-title":null,"doi-asserted-by":null},{"DOI":"10.1093/cid/ciz1008","key":"10.1016/S1473-3099(25)00550-X_bib7","year":"2020","issue":null,"author":"Donnelly","volume":"71","first-page":"1367","unstructured":null,"article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","journal-title":"Clin Infect Dis","doi-asserted-by":"crossref"},{"DOI":null,"key":"10.1016/S1473-3099(25)00550-X_bib8","year":"2022","issue":null,"author":"Abdolrasouli","volume":null,"first-page":null,"unstructured":null,"article-title":"Microscopic examination of clinical specimens","journal-title":null,"doi-asserted-by":null},{"DOI":"10.1016/S1473-3099(19)30312-3","key":"10.1016/S1473-3099(25)00550-X_bib9","year":"2019","issue":null,"author":"Cornely","volume":"19","first-page":"e405","unstructured":null,"article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","journal-title":"Lancet Infect Dis","doi-asserted-by":"crossref"},{"DOI":"10.1016/S1473-3099(21)00203-6","key":"10.1016/S1473-3099(25)00550-X_bib10","year":"2021","issue":null,"author":"Chen","volume":"21","first-page":"e375","unstructured":null,"article-title":"Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM","journal-title":"Lancet Infect Dis","doi-asserted-by":"crossref"},{"DOI":"10.1016/S1473-3099(20)30784-2","key":"10.1016/S1473-3099(25)00550-X_bib11","year":"2021","issue":null,"author":"Hoenigl","volume":"21","first-page":"e246","unstructured":null,"article-title":null,"journal-title":"Lancet Infect Dis","doi-asserted-by":"crossref"},{"DOI":"10.1034/j.1399-3003.2000.15b30.x","key":"10.1016/S1473-3099(25)00550-X_bib12","year":"2000","issue":null,"author":"Andreas","volume":"15","first-page":"407","unstructured":null,"article-title":"Diagnosis of pulmonary aspergillosis using optical brighteners","journal-title":"Eur Respir J","doi-asserted-by":"crossref"},{"DOI":"10.1128/jcm.22.2.292-295.1985","key":"10.1016/S1473-3099(25)00550-X_bib13","year":"1985","issue":null,"author":"Plorde","volume":"22","first-page":"292","unstructured":null,"article-title":"Specimen volume versus yield in the BACTEC blood culture system","journal-title":"J Clin Microbiol","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.cmi.2019.11.019","key":"10.1016/S1473-3099(25)00550-X_bib14","year":"2020","issue":null,"author":"Vergidis","volume":"26","first-page":"935","unstructured":null,"article-title":"High-volume culture and quantitative real-time PCR for the detection of Aspergillus in sputum","journal-title":"Clin Microbiol Infect","doi-asserted-by":"crossref"},{"DOI":"10.1016/S1473-3099(21)00066-9","key":"10.1016/S1473-3099(25)00550-X_bib15","year":"2021","issue":null,"author":"Jabeen","volume":"21","first-page":"767","unstructured":null,"article-title":"Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis","journal-title":"Lancet Infect Dis","doi-asserted-by":"crossref"},{"DOI":"10.1128/JCM.00913-12","key":"10.1016/S1473-3099(25)00550-X_bib16","year":"2012","issue":null,"author":"Borman","volume":"50","first-page":"2639","unstructured":null,"article-title":"Assessment of accuracy of identification of pathogenic yeasts in microbiology laboratories in the United Kingdom","journal-title":"J Clin Microbiol","doi-asserted-by":"crossref"},{"DOI":"10.1093/jac/dkz568","key":"10.1016/S1473-3099(25)00550-X_bib17","year":"2020","issue":null,"author":"Borman","volume":"75","first-page":"1194","unstructured":null,"article-title":"MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution method","journal-title":"J Antimicrob Chemother","doi-asserted-by":"crossref"},{"DOI":null,"key":"10.1016/S1473-3099(25)00550-X_bib19","year":"2016","issue":null,"author":"Fraser","volume":"54","first-page":"80","unstructured":null,"article-title":"Rapid identification of 6328 isolates of pathogenic yeasts using MALDI-ToF MS and a simplified, rapid extraction procedure that is compatible with the Bruker Biotyper platform and database","journal-title":"Med Mycol","doi-asserted-by":null},{"DOI":"10.1128/JCM.02061-06","key":"10.1016/S1473-3099(25)00550-X_bib20","year":"2007","issue":null,"author":"Linton","volume":"45","first-page":"1152","unstructured":null,"article-title":"Molecular identification of unusual pathogenic yeast isolates by large ribosomal subunit gene sequencing: 2 years of experience at the United Kingdom Mycology Reference Laboratory","journal-title":"J Clin Microbiol","doi-asserted-by":"crossref"},{"DOI":"10.1128/EC.4.3.625-632.2005","key":"10.1016/S1473-3099(25)00550-X_bib21","year":"2005","issue":null,"author":"Balajee","volume":"4","first-page":"625","unstructured":null,"article-title":"Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus","journal-title":"Eukaryot Cell","doi-asserted-by":"crossref"},{"DOI":"10.1128/jcm.00873-23","key":"10.1016/S1473-3099(25)00550-X_bib22","year":"2023","issue":null,"author":"de Hoog","volume":"61","first-page":null,"unstructured":null,"article-title":"A conceptual framework for nomenclatural stability and validity of medically important fungi: a proposed global consensus guideline for fungal name changes supported by ABP, ASM, CLSI, ECMM, ESCMID-EFISG, EUCAST-AFST, FDLC, IDSA, ISHAM, MMSA, and MSGERC","journal-title":"J Clin Microbiol","doi-asserted-by":"crossref"},{"DOI":"10.1016/S1473-3099(24)00749-7","key":"10.1016/S1473-3099(25)00550-X_bib23","year":"2025","issue":null,"author":"Cornely","volume":"25","first-page":"e280","unstructured":null,"article-title":"Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM","journal-title":"Lancet Infect Dis","doi-asserted-by":"crossref"},{"DOI":"10.1016/S1473-3099(24)00429-8","key":"10.1016/S1473-3099(25)00550-X_bib24","year":"2024","issue":null,"author":"Kwizera","volume":"24","first-page":"e782","unstructured":null,"article-title":"Antifungal susceptibility testing: applicability of methods and strategies for improving access in resource-constrained settings","journal-title":"Lancet Infect Dis","doi-asserted-by":"crossref"},{"DOI":null,"key":"10.1016/S1473-3099(25)00550-X_bib25","year":"2020","issue":null,"author":"Pelzer","volume":"58","first-page":"268","unstructured":null,"article-title":"Performance of the AsperGenius® PCR assay for detecting azole resistant Aspergillus fumigatus in BAL fluids from allogeneic HSCT recipients: a prospective cohort study from Essen, West Germany","journal-title":"Med Mycol","doi-asserted-by":null},{"DOI":"10.3201/eid2001.130906","key":"10.1016/S1473-3099(25)00550-X_bib26","year":"2014","issue":null,"author":"Boulware","volume":"20","first-page":"45","unstructured":null,"article-title":"Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast","journal-title":"Emerg Infect Dis","doi-asserted-by":"crossref"},{"DOI":"10.1093/cid/cix872","key":"10.1016/S1473-3099(25)00550-X_bib27","year":"2018","issue":null,"author":"Wake","volume":"66","first-page":"686","unstructured":null,"article-title":"High cryptococcal antigen titers in blood are predictive of subclinical cryptococcal meningitis among human immunodeficiency virus-infected patients","journal-title":"Clin Infect Dis","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.cmi.2024.03.031","key":"10.1016/S1473-3099(25)00550-X_bib28","year":"2024","issue":null,"author":"Paccoud","volume":"30","first-page":"937","unstructured":null,"article-title":"Features of cryptococcosis among 652 HIV-seronegative individuals in France: a cross-sectional observational study (2005–2020)","journal-title":"Clin Microbiol Infect","doi-asserted-by":"crossref"},{"DOI":"10.1093/mmy/myx010","key":"10.1016/S1473-3099(25)00550-X_bib29","year":"2018","issue":null,"author":"Oshima","volume":"56","first-page":"88","unstructured":null,"article-title":"Examination of cryptococcal glucuronoxylomannan antigen in bronchoalveolar lavage fluid for diagnosing pulmonary cryptococcosis in HIV-negative patients","journal-title":"Med Mycol","doi-asserted-by":"crossref"},{"DOI":"10.1128/JCM.02837-20","key":"10.1016/S1473-3099(25)00550-X_bib30","year":"2021","issue":null,"author":"Shi","volume":"59","first-page":"e02837","unstructured":null,"article-title":"Neglecting genetic diversity hinders timely diagnosis of Cryptococcus infections","journal-title":"J Clin Microbiol","doi-asserted-by":"crossref"},{"DOI":"10.1016/S1473-3099(23)00731-4","key":"10.1016/S1473-3099(25)00550-X_bib31","year":"2024","issue":null,"author":"Chang","volume":"24","first-page":"e495","unstructured":null,"article-title":"Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM","journal-title":"Lancet Infect Dis","doi-asserted-by":"crossref"},{"DOI":"10.1093/mmy/myad061","key":"10.1016/S1473-3099(25)00550-X_bib32","year":"2023","issue":null,"author":"Lamoth","volume":"61","first-page":null,"unstructured":null,"article-title":"Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis","journal-title":"Med Mycol","doi-asserted-by":"crossref"},{"DOI":"10.3390/ijms18061124","key":"10.1016/S1473-3099(25)00550-X_bib33","year":"2017","issue":null,"author":"McCarthy","volume":"18","first-page":null,"unstructured":null,"article-title":"Translational development and application of (1→3)-β-d-glucan for diagnosis and therapeutic monitoring of invasive mycoses","journal-title":"Int J Mol Sci","doi-asserted-by":"crossref"},{"DOI":"10.3390/jof7010014","key":"10.1016/S1473-3099(25)00550-X_bib34","year":"2020","issue":null,"author":"Finkelman","volume":"7","first-page":"14","unstructured":null,"article-title":"Specificity influences in (1→3)-β-d-glucan-supported diagnosis of invasive fungal disease","journal-title":"J Fungi","doi-asserted-by":"crossref"},{"DOI":"10.1093/jac/dkw156","key":"10.1016/S1473-3099(25)00550-X_bib35","year":"2016","issue":null,"author":"Alanio","volume":"71","first-page":"2386","unstructured":null,"article-title":"ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients","journal-title":"J Antimicrob Chemother","doi-asserted-by":"crossref"},{"DOI":"10.1093/ofid/ofac234","key":"10.1016/S1473-3099(25)00550-X_bib36","year":"2022","issue":null,"author":"Chakrabarti","volume":"9","first-page":null,"unstructured":null,"article-title":"The role of diagnostics-driven antifungal stewardship in the management of invasive fungal infections: a systematic literature review","journal-title":"Open Forum Infect Dis","doi-asserted-by":"crossref"},{"DOI":null,"key":"10.1016/S1473-3099(25)00550-X_bib37","year":"2015","issue":null,"author":"Leeflang","volume":"12","first-page":null,"unstructured":null,"article-title":"Galactomannan detection for invasive aspergillosis in immunocompromised patients","journal-title":"Cochrane Database Syst Rev","doi-asserted-by":null},{"DOI":"10.1128/JCM.06423-11","key":"10.1016/S1473-3099(25)00550-X_bib38","year":"2012","issue":null,"author":"D'Haese","volume":"50","first-page":"1258","unstructured":null,"article-title":"Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity","journal-title":"J Clin Microbiol","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.cmi.2018.01.002","key":"10.1016/S1473-3099(25)00550-X_bib39","year":"2018","issue":"suppl 1","author":"Ullmann","volume":"24","first-page":"e1","unstructured":null,"article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","journal-title":"Clin Microbiol Infect","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.cmi.2019.05.019","key":"10.1016/S1473-3099(25)00550-X_bib40","year":"2019","issue":null,"author":"Warris","volume":"25","first-page":"1096","unstructured":null,"article-title":"ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children","journal-title":"Clin Microbiol Infect","doi-asserted-by":"crossref"},{"DOI":"10.3390/jof9060674","key":"10.1016/S1473-3099(25)00550-X_bib41","year":"2023","issue":null,"author":"Bukkems","volume":"9","first-page":"674","unstructured":null,"article-title":"The use of galactomannan antigen assays for the diagnosis of invasive pulmonary aspergillosis in the hematological patient: a systematic review and meta-analysis","journal-title":"J Fungi","doi-asserted-by":"crossref"},{"DOI":"10.1128/JCM.00750-11","key":"10.1016/S1473-3099(25)00550-X_bib42","year":"2012","issue":null,"author":"Bergeron","volume":"50","first-page":"823","unstructured":null,"article-title":"Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients","journal-title":"J Clin Microbiol","doi-asserted-by":"crossref"},{"DOI":"10.1200/JCO.2002.07.004","key":"10.1016/S1473-3099(25)00550-X_bib43","year":"2002","issue":null,"author":"Herbrecht","volume":"20","first-page":"1898","unstructured":null,"article-title":"Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients","journal-title":"J Clin Oncol","doi-asserted-by":"crossref"},{"DOI":"10.1183/13993003.00583-2015","key":"10.1016/S1473-3099(25)00550-X_bib44","year":"2016","issue":null,"author":"Denning","volume":"47","first-page":"45","unstructured":null,"article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","journal-title":"Eur Respir J","doi-asserted-by":"crossref"},{"DOI":"10.1183/13993003.00061-2024","key":"10.1016/S1473-3099(25)00550-X_bib45","year":"2024","issue":null,"author":"Agarwal","volume":"63","first-page":null,"unstructured":null,"article-title":"Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses","journal-title":"Eur Respir J","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.cmi.2023.02.002","key":"10.1016/S1473-3099(25)00550-X_bib46","year":"2023","issue":null,"author":"Lu","volume":"29","first-page":"797e1","unstructured":null,"article-title":"The clinical value of Aspergillus-specific IgG antibody test in the diagnosis of nonneutropenic invasive pulmonary aspergillosis","journal-title":"Clin Microbiol Infect","doi-asserted-by":"crossref"},{"DOI":"10.1177/14799731251326592","key":"10.1016/S1473-3099(25)00550-X_bib47","year":"2025","issue":null,"author":"Hatim","volume":"22","first-page":null,"unstructured":null,"article-title":"Aspergillus IgG antibody testing in the diagnosis of hypersensitivity pneumonitis: a scoping review","journal-title":"Chron Respir Dis","doi-asserted-by":"crossref"},{"DOI":"10.1128/JCM.02690-14","key":"10.1016/S1473-3099(25)00550-X_bib48","year":"2015","issue":null,"author":"Oliva","volume":"53","first-page":"248","unstructured":null,"article-title":"Evaluation of the Aspergillus Western blot IgG kit for diagnosis of chronic aspergillosis","journal-title":"J Clin Microbiol","doi-asserted-by":"crossref"},{"DOI":"10.3390/jof7040311","key":"10.1016/S1473-3099(25)00550-X_bib49","year":"2021","issue":null,"author":"Rozaliyani","volume":"7","first-page":"311","unstructured":null,"article-title":"Performance of LDBio Aspergillus WB and ICT antibody detection in chronic pulmonary aspergillosis","journal-title":"J Fungi","doi-asserted-by":"crossref"},{"DOI":"10.1111/myc.13035","key":"10.1016/S1473-3099(25)00550-X_bib50","year":"2020","issue":null,"author":"Wang","volume":"63","first-page":"181","unstructured":null,"article-title":"Diagnostic value of Candida mannan antigen and anti-mannan IgG and IgM antibodies for Candida infection","journal-title":"Mycoses","doi-asserted-by":"crossref"},{"DOI":"10.1093/jac/dkv090","key":"10.1016/S1473-3099(25)00550-X_bib51","year":"2015","issue":null,"author":"Martínez-Jiménez","volume":"70","first-page":"2354","unstructured":null,"article-title":"Candida biomarkers in patients with candidaemia and bacteraemia","journal-title":"J Antimicrob Chemother","doi-asserted-by":"crossref"},{"DOI":"10.3390/jof9080813","key":"10.1016/S1473-3099(25)00550-X_bib52","year":"2023","issue":null,"author":"Eades","volume":"9","first-page":"813","unstructured":null,"article-title":"Comparison of β-1–3-d-glucan and Candida mannan biomarker assays with serological tests for the diagnosis of candidemia","journal-title":"J Fungi","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.alit.2023.07.003","key":"10.1016/S1473-3099(25)00550-X_bib53","year":"2023","issue":null,"author":"Denning","volume":"72","first-page":"493","unstructured":null,"article-title":"Poorly controlled asthma - easy wins and future prospects for addressing fungal allergy","journal-title":"Allergol Int","doi-asserted-by":"crossref"},{"DOI":"10.1371/journal.pone.0098502","key":"10.1016/S1473-3099(25)00550-X_bib54","year":"2014","issue":null,"author":"Armstead","volume":"9","first-page":null,"unstructured":null,"article-title":"Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis","journal-title":"PLoS One","doi-asserted-by":"crossref"},{"DOI":"10.1093/cid/ciae239","key":"10.1016/S1473-3099(25)00550-X_bib55","year":"2024","issue":null,"author":"Brown","volume":"79","first-page":"161","unstructured":null,"article-title":"Polymerase chain reaction on respiratory tract specimens of immunocompromised patients to diagnose Pneumocystis pneumonia: a systematic review and meta-analysis","journal-title":"Clin Infect Dis","doi-asserted-by":"crossref"},{"DOI":"10.1093/mmy/myaf023","key":"10.1016/S1473-3099(25)00550-X_bib56","year":"2025","issue":null,"author":"Ghelfenstein-Ferreira","volume":"63","first-page":null,"unstructured":null,"article-title":"Multicentric prospective evaluation of Pneumocystis jirovecii fungal load in bronchoalveolar lavage fluid fractions using qPCR","journal-title":"Med Mycol","doi-asserted-by":"crossref"},{"DOI":"10.1093/mmy/myz115","key":"10.1016/S1473-3099(25)00550-X_bib57","year":"2020","issue":null,"author":"Gits-Muselli","volume":"58","first-page":"779","unstructured":null,"article-title":"The Fungal PCR Initiative's evaluation of in-house and commercial Pneumocystis jirovecii qPCR assays: toward a standard for a diagnostics assay","journal-title":"Med Mycol","doi-asserted-by":"crossref"},{"DOI":"10.1128/JCM.00905-15","key":"10.1016/S1473-3099(25)00550-X_bib58","year":"2015","issue":null,"author":"White","volume":"53","first-page":"2832","unstructured":null,"article-title":"Clinical performance of Aspergillus PCR for testing serum and plasma: a study by the European Aspergillus PCR Initiative","journal-title":"J Clin Microbiol","doi-asserted-by":"crossref"},{"DOI":"10.1128/JCM.02814-15","key":"10.1016/S1473-3099(25)00550-X_bib59","year":"2016","issue":null,"author":"Springer","volume":"54","first-page":"705","unstructured":null,"article-title":"Comparison of performance characteristics of Aspergillus PCR in testing a range of blood-based samples in accordance with international methodological recommendations","journal-title":"J Clin Microbiol","doi-asserted-by":"crossref"},{"DOI":"10.1128/JCM.01767-09","key":"10.1016/S1473-3099(25)00550-X_bib60","year":"2010","issue":null,"author":"White","volume":"48","first-page":"1231","unstructured":null,"article-title":"Aspergillus PCR: one step closer to standardization","journal-title":"J Clin Microbiol","doi-asserted-by":"crossref"},{"DOI":null,"key":"10.1016/S1473-3099(25)00550-X_bib61","year":"2019","issue":null,"author":"Cruciani","volume":"9","first-page":null,"unstructured":null,"article-title":"Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people","journal-title":"Cochrane Database Syst Rev","doi-asserted-by":null},{"DOI":"10.1093/cid/ciaa1865","key":"10.1016/S1473-3099(25)00550-X_bib62","year":"2021","issue":"suppl 2","author":"White","volume":"72","first-page":"S95","unstructured":null,"article-title":"Aspergillus polymerase chain reaction-an update on technical recommendations, clinical applications, and justification for inclusion in the second revision of the EORTC/MSGERC definitions of invasive fungal disease","journal-title":"Clin Infect Dis","doi-asserted-by":"crossref"},{"DOI":"10.1186/s12890-023-02343-5","key":"10.1016/S1473-3099(25)00550-X_bib63","year":"2023","issue":null,"author":"Han","volume":"23","first-page":"58","unstructured":null,"article-title":"Bronchoalveolar lavage fluid polymerase chain reaction for invasive pulmonary aspergillosis among high-risk patients: a diagnostic meta-analysis","journal-title":"BMC Pulm Med","doi-asserted-by":"crossref"},{"DOI":null,"key":"10.1016/S1473-3099(25)00550-X_bib64","year":"2007","issue":null,"author":"Tuon","volume":"24","first-page":"89","unstructured":null,"article-title":"A systematic literature review on the diagnosis of invasive aspergillosis using polymerase chain reaction (PCR) from bronchoalveolar lavage clinical samples","journal-title":"Rev Iberoam Micol","doi-asserted-by":null},{"DOI":"10.1371/journal.pone.0028467","key":"10.1016/S1473-3099(25)00550-X_bib65","year":"2011","issue":null,"author":"Sun","volume":"6","first-page":null,"unstructured":null,"article-title":"Evaluation of PCR on bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis: a bivariate metaanalysis and systematic review","journal-title":"PLoS One","doi-asserted-by":"crossref"},{"DOI":"10.1128/JCM.00942-12","key":"10.1016/S1473-3099(25)00550-X_bib66","year":"2012","issue":null,"author":"Avni","volume":"50","first-page":"3652","unstructured":null,"article-title":"Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review","journal-title":"J Clin Microbiol","doi-asserted-by":"crossref"},{"DOI":"10.1128/JCM.01602-10","key":"10.1016/S1473-3099(25)00550-X_bib67","year":"2011","issue":null,"author":"Avni","volume":"49","first-page":"665","unstructured":null,"article-title":"PCR diagnosis of invasive candidiasis: systematic review and meta-analysis","journal-title":"J Clin Microbiol","doi-asserted-by":"crossref"},{"DOI":"10.1128/JCM.01909-17","key":"10.1016/S1473-3099(25)00550-X_bib68","year":"2018","issue":null,"author":"Clancy","volume":"56","first-page":"e01909","unstructured":null,"article-title":"Diagnosing invasive candidiasis","journal-title":"J Clin Microbiol","doi-asserted-by":"crossref"},{"DOI":"10.1093/jac/dkac161","key":"10.1016/S1473-3099(25)00550-X_bib69","year":"2022","issue":null,"author":"Rogers","volume":"77","first-page":"2053","unstructured":null,"article-title":"Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications","journal-title":"J Antimicrob Chemother","doi-asserted-by":"crossref"},{"DOI":"10.1128/jcm.00158-24","key":"10.1016/S1473-3099(25)00550-X_bib70","year":"2024","issue":null,"author":"Franco","volume":"62","first-page":null,"unstructured":null,"article-title":"Validation of a qualitative real-time PCR assay for the detection of Candida auris in hospital inpatient screening","journal-title":"J Clin Microbiol","doi-asserted-by":"crossref"},{"DOI":"10.1128/JCM.00630-19","key":"10.1016/S1473-3099(25)00550-X_bib71","year":"2019","issue":null,"author":"Leach","volume":"57","first-page":"e00630","unstructured":null,"article-title":"A rapid and automated sample-to-result Candida auris real-time pcr assay for high-throughput testing of surveillance samples with the BD Max open system","journal-title":"J Clin Microbiol","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.eclinm.2025.103115","key":"10.1016/S1473-3099(25)00550-X_bib72","year":"2025","issue":null,"author":"Brown","volume":"81","first-page":null,"unstructured":null,"article-title":"The diagnosis of mucormycosis by PCR in patients at risk: a systematic review and meta-analysis","journal-title":"EClinicalMedicine","doi-asserted-by":"crossref"},{"DOI":"10.1111/myc.12837","key":"10.1016/S1473-3099(25)00550-X_bib73","year":"2018","issue":null,"author":"Gholinejad-Ghadi","volume":"61","first-page":"909","unstructured":null,"article-title":"Identification of Mucorales in patients with proven invasive mucormycosis by polymerase chain reaction in tissue samples","journal-title":"Mycoses","doi-asserted-by":"crossref"},{"DOI":"10.1093/mmy/myae030","key":"10.1016/S1473-3099(25)00550-X_bib74","year":"2024","issue":null,"author":"Bellanger","volume":"62","first-page":null,"unstructured":null,"article-title":"Use of the Mucorales qPCR on blood to screen high-risk hematology patients is associated with better survival","journal-title":"Med Mycol","doi-asserted-by":"crossref"},{"DOI":"10.1093/mmy/myac004","key":"10.1016/S1473-3099(25)00550-X_bib75","year":"2022","issue":null,"author":"Clark","volume":"60","first-page":null,"unstructured":null,"article-title":"Assessment of panfungal PCR performance with formalin-fixed paraffin-embedded tissue specimens","journal-title":"Med Mycol","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.pathol.2023.03.011","key":"10.1016/S1473-3099(25)00550-X_bib76","year":"2023","issue":null,"author":"Sparks","volume":"55","first-page":"669","unstructured":null,"article-title":"Panfungal PCR on formalin-fixed, paraffin-embedded tissue: to proceed or not proceed?","journal-title":"Pathology","doi-asserted-by":"crossref"},{"DOI":"10.1164/rccm.202305-0901OC","key":"10.1016/S1473-3099(25)00550-X_bib77","year":"2024","issue":null,"author":"Charalampous","volume":"209","first-page":"164","unstructured":null,"article-title":"Routine metagenomics service for ICU patients with respiratory infection","journal-title":"Am J Respir Crit Care Med","doi-asserted-by":"crossref"},{"DOI":"10.1093/jac/dkt508","key":"10.1016/S1473-3099(25)00550-X_bib78","year":"2014","issue":null,"author":"Ashbee","volume":"69","first-page":"1162","unstructured":null,"article-title":"Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology","journal-title":"J Antimicrob Chemother","doi-asserted-by":"crossref"},{"DOI":"10.1097/FTD.0000000000000931","key":"10.1016/S1473-3099(25)00550-X_bib79","year":"2022","issue":null,"author":"Kim","volume":"44","first-page":"198","unstructured":null,"article-title":"Therapeutic drug monitoring of the echinocandin antifungal agents: is there a role in clinical practice? A position statement of the Anti-Infective Drugs Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology","journal-title":"Ther Drug Monit","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.mmcr.2012.12.006","key":"10.1016/S1473-3099(25)00550-X_bib80","year":"2012","issue":null,"author":"Koch","volume":"2","first-page":"23","unstructured":null,"article-title":"Insufficient serum caspofungin levels in a paediatric patient on ECMO","journal-title":"Med Mycol Case Rep","doi-asserted-by":"crossref"},{"DOI":"10.1007/s40262-023-01264-0","key":"10.1016/S1473-3099(25)00550-X_bib81","year":"2023","issue":null,"author":"Lyster","volume":"62","first-page":"931","unstructured":null,"article-title":"Antifungal dosing in critically ill patients on extracorporeal membrane oxygenation","journal-title":"Clin Pharmacokinet","doi-asserted-by":"crossref"},{"DOI":"10.1093/jac/dkad293","key":"10.1016/S1473-3099(25)00550-X_bib82","year":"2023","issue":null,"author":"Boglione-Kerrien","volume":"78","first-page":"2630","unstructured":null,"article-title":"Can we predict the influence of inflammation on voriconazole exposure? An overview","journal-title":"J Antimicrob Chemother","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.ijantimicag.2023.106750","key":"10.1016/S1473-3099(25)00550-X_bib83","year":"2023","issue":null,"author":"van den Born","volume":"61","first-page":null,"unstructured":null,"article-title":"Voriconazole exposure is influenced by inflammation: a population pharmacokinetic model","journal-title":"Int J Antimicrob Agents","doi-asserted-by":"crossref"},{"DOI":"10.1007/s40272-023-00616-4","key":"10.1016/S1473-3099(25)00550-X_bib84","year":"2024","issue":null,"author":"Taher","volume":"26","first-page":"197","unstructured":null,"article-title":"Therapeutic drug monitoring of voriconazole in critically ill pediatric patients: a single-center retrospective study","journal-title":"Paediatr Drugs","doi-asserted-by":"crossref"},{"DOI":"10.1002/jcph.2254","key":"10.1016/S1473-3099(25)00550-X_bib85","year":"2023","issue":null,"author":"Xie","volume":"63","first-page":"993","unstructured":null,"article-title":"Optimization of voriconazole dosing regimens against Aspergillus species and Candida species in pediatric patients after hematopoietic cell transplantation: a theoretical study based on pharmacokinetic/pharmacodynamic analysis","journal-title":"J Clin Pharmacol","doi-asserted-by":"crossref"},{"DOI":"10.1128/aac.00829-23","key":"10.1016/S1473-3099(25)00550-X_bib86","year":"2023","issue":null,"author":"Fernández Ledesma","volume":"67","first-page":null,"unstructured":null,"article-title":"Isavuconazole use and TDM in real-world pediatric practice","journal-title":"Antimicrob Agents Chemother","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.cmi.2016.04.022","key":"10.1016/S1473-3099(25)00550-X_bib87","year":"2016","issue":null,"author":"Aye","volume":"22","first-page":"632","unstructured":null,"article-title":"Cryptococcosis-the impact of delay to diagnosis","journal-title":"Clin Microbiol Infect","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.eclinm.2020.100563","key":"10.1016/S1473-3099(25)00550-X_bib88","year":"2020","issue":null,"author":"Salazar","volume":"27","first-page":null,"unstructured":null,"article-title":"Potential missed opportunities for diagnosis of cryptococcosis and the association with mortality: a cohort study","journal-title":"EClinicalMedicine","doi-asserted-by":"crossref"},{"DOI":"10.5334/aogh.3524","key":"10.1016/S1473-3099(25)00550-X_bib89","year":"2022","issue":null,"author":"Link","volume":"88","first-page":"22","unstructured":null,"article-title":"Delays in cryptococcal meningitis diagnosis and care: a mixed methods study in rural Uganda","journal-title":"Ann Glob Health","doi-asserted-by":"crossref"},{"DOI":"10.1111/myc.12628","key":"10.1016/S1473-3099(25)00550-X_bib90","year":"2017","issue":null,"author":"Cornely","volume":"60","first-page":"420","unstructured":null,"article-title":"Improving outcome of fungal diseases - guiding experts and patients towards excellence","journal-title":"Mycoses","doi-asserted-by":"crossref"},{"DOI":"10.1056/NEJMp1606458","key":"10.1016/S1473-3099(25)00550-X_bib91","year":"2016","issue":null,"author":"Bohmer","volume":"375","first-page":"709","unstructured":null,"article-title":"The hard work of health care transformation","journal-title":"N Engl J Med","doi-asserted-by":"crossref"}],"updated-by":[{"DOI":"10.1016/s1473-3099(25)00724-8","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000,"date-parts":[[2025,11,19]]}}],"short-title":[],"update-policy":"https://doi.org/10.1016/elsevier_cm_policy","alternative-id":["S147330992500550X"],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"original-title":[],"container-title":["The Lancet Infectious Diseases"],"published-print":{"date-parts":[[2025,11]]},"reference-count":90,"published-online":null,"references-count":90,"short-container-title":["The Lancet Infectious Diseases"],"is-referenced-by-count":0},"unpaywall":{"doi":"10.1016/s1473-3099(25)00550-x","is_oa":false,"title":"British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases: 2025 update","updated":"2025-11-13T08:10:39+00:00","published_date":"2025-11-01","best_oa_location":null}},"created_at":"2025-12-04T03:42:26.941Z","updated_at":"2025-12-04T03:42:26.941Z","tags":[{"paper_doi":"10.1016/s1473-3099(25)00550-x","tag_type":"age_group","value":"adult","value_numeric":null},{"paper_doi":"10.1016/s1473-3099(25)00550-x","tag_type":"category","value":"Infectious Diseases","value_numeric":null},{"paper_doi":"10.1016/s1473-3099(25)00550-x","tag_type":"condition","value":"Aspergillosis","value_numeric":null},{"paper_doi":"10.1016/s1473-3099(25)00550-x","tag_type":"condition","value":"Invasive Candidiasis","value_numeric":null},{"paper_doi":"10.1016/s1473-3099(25)00550-x","tag_type":"condition","value":"Invasive Fungal Disease","value_numeric":null},{"paper_doi":"10.1016/s1473-3099(25)00550-x","tag_type":"condition","value":"Mucormycosis","value_numeric":null},{"paper_doi":"10.1016/s1473-3099(25)00550-x","tag_type":"condition","value":"Pneumocystis Pneumonia","value_numeric":null},{"paper_doi":"10.1016/s1473-3099(25)00550-x","tag_type":"generic","value":"isavuconazole","value_numeric":null},{"paper_doi":"10.1016/s1473-3099(25)00550-x","tag_type":"generic","value":"posaconazole","value_numeric":null},{"paper_doi":"10.1016/s1473-3099(25)00550-x","tag_type":"impact_flag","value":"practice_changing","value_numeric":null},{"paper_doi":"10.1016/s1473-3099(25)00550-x","tag_type":"study_design","value":"Guideline","value_numeric":null},{"paper_doi":"10.1016/s1473-3099(25)00550-x","tag_type":"warning","value":"No sample size or quantitative performance metrics are provided in the abstract.","value_numeric":null},{"paper_doi":"10.1016/s1473-3099(25)00550-x","tag_type":"warning","value":"Specific indications and thresholds for individual tests are not detailed in the abstract.","value_numeric":null},{"paper_doi":"10.1016/s1473-3099(25)00550-x","tag_type":"warning","value":"This is an expert consensus guideline, not a clinical trial with outcomes.","value_numeric":null}],"summaries":{"what_studied":"An expert group updated best practice recommendations for diagnosing serious fungal diseases in the UK, focusing on adults, with test-specific guidance and expected turnaround times; histopathology and radiology guidance remain as in 2015.","key_result":"New or stronger recommendations: use Pneumocystis PCR; use 1,3-β-D-glucan for suspected invasive candidiasis and Pneumocystis pneumonia; collect higher-volume respiratory samples for culture; broaden Aspergillus antigen/antibody testing to ICU patients and those with chronic respiratory disease (including asthma); use Candida PCR and Mucorales PCR in specific contexts; apply pan-fungal PCR/DNA sequencing for identification from positive microscopy or histopathology; include posaconazole and isavuconazole in therapeutic drug monitoring.","limitations":"Access to tests and turnaround times vary across the UK, which may limit implementation; recommendations focus on adults and UK practice, with pediatric and global applicability only discussed, not specified.","practice_takeaway":"Adopt non-culture diagnostics alongside stewardship: order Pneumocystis PCR and 1,3-β-D-glucan when PCP or invasive candidiasis is suspected; use higher-volume respiratory cultures; expand Aspergillus antigen/antibody testing to ICU and chronic lung disease; consider Candida and Mucorales PCR where appropriate; use pan-fungal PCR/sequencing when microscopy or histology is positive; monitor posaconazole and isavuconazole levels."}},{"doi":"10.1111/jdv.70115","pmid":"41104791","title":"Deep and disseminated dermatophytosis in immunocompromised populations—A systematic review","journal_title":"Journal of the European Academy of Dermatology and Venereology","journal_issn":"0926-9959","published_at":"2025-10-17T00:00:00.000Z","url":"https://doi.org/10.1111/jdv.70115","source_score":2,"is_retracted":false,"is_open_access":true,"raw_metadata":{"ooir":{"day":"2025-10-22","doi":"10.1111/jdv.70115","days":"7","issn":"0926-9959","rank":"10","field":"Clinical Medicine","score":"2","category":"Dermatology","categories":["Dermatology"],"_categories":["Dermatology"]},"pubmed":{"doi":"10.1111/jdv.70115","title":"Deep and disseminated dermatophytosis in immunocompromised populations-A systematic review.","journal":"Journal of the European Academy of Dermatology and Venereology : JEADV","methods":"","results":"$31","abstract":"$32","keywords":["deep dermatophytosis","dermatophyte","disseminated fungal infection","invasive fungal infection","ringworm","tinea"],"pubmed_id":"41104791","conclusions":"","publication_date":"2025-10-17T00:00:00"},"crossref":{"DOI":"10.1111/jdv.70115","URL":"https://doi.org/10.1111/jdv.70115","ISSN":["0926-9959","1468-3083"],"link":[{"URL":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.70115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"page":null,"type":"journal-article","issue":null,"score":1,"title":["Deep and disseminated dermatophytosis in immunocompromised populations—A systematic review"],"author":[{"given":"Aditya K.","family":"Gupta","sequence":"first","affiliation":[{"name":"Division of Dermatology, Department of Medicine, Temerty Faculty of Medicine University of Toronto Toronto Ontario Canada"},{"name":"Mediprobe Research Inc. London Ontario Canada"}]},{"given":"Tong","family":"Wang","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc. London Ontario Canada"}]},{"given":null,"family":"Susmita","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc. London Ontario Canada"}]},{"given":"Ditte Marie L.","family":"Saunte","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark"},{"name":"Department of Allergy and Dermatology Copenhagen University Hospital – Herlev and Gentofte Gentofte Denmark"}]},{"given":"Roderick","family":"Hay","sequence":"additional","affiliation":[{"name":"St. John's Institute of Dermatology King's College London London UK"}]},{"given":"Vincent","family":"Piguet","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, Temerty Faculty of Medicine University of Toronto Toronto Ontario Canada"},{"name":"Division of Dermatology Women's College Hospital Toronto Ontario Canada"}]}],"issued":{"date-parts":[[2025,10,17]]},"member":"311","prefix":"10.1111","source":"Crossref","volume":null,"archive":["Portico"],"created":{"date-time":"2025-10-17T12:01:38Z","timestamp":1760702498000,"date-parts":[[2025,10,17]]},"indexed":{"date-time":"2025-10-17T12:41:13Z","timestamp":1760704873842,"date-parts":[[2025,10,17]]},"license":[{"URL":"http://creativecommons.org/licenses/by-nc-nd/4.0/","start":{"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000,"date-parts":[[2025,10,17]]},"delay-in-days":0,"content-version":"vor"}],"subject":[],"abstract":"$33","language":"en","relation":{},"resource":{"primary":{"URL":"https://onlinelibrary.wiley.com/doi/10.1111/jdv.70115"}},"subtitle":[],"assertion":[{"name":"received","group":{"name":"publication_history","label":"Publication History"},"label":"Received","order":0,"value":"2025-08-06"},{"name":"accepted","group":{"name":"publication_history","label":"Publication History"},"label":"Accepted","order":2,"value":"2025-09-24"},{"name":"published","group":{"name":"publication_history","label":"Publication History"},"label":"Published","order":3,"value":"2025-10-17"}],"deposited":{"date-time":"2025-10-17T12:01:54Z","timestamp":1760702514000,"date-parts":[[2025,10,17]]},"issn-type":[{"type":"print","value":"0926-9959"},{"type":"electronic","value":"1468-3083"}],"published":{"date-parts":[[2025,10,17]]},"publisher":"Wiley","reference":[{"DOI":"10.3389/fpubh.2025.1580221","key":"e_1_2_12_2_1","year":"2025","issue":null,"author":"Li D","volume":"13","first-page":null,"unstructured":null,"article-title":"Worldwide trends and future projections of fungal skin disease burden: a comprehensive analysis from the Global Burden of Diseases Study 2021","journal-title":"Front Public Health","doi-asserted-by":"crossref"},{"DOI":null,"key":"e_1_2_12_3_1","year":"2025","issue":null,"author":"Gupta AK","volume":null,"first-page":null,"unstructured":null,"article-title":"Trichophyton indotineae: epidemiology, antifungal resistance and antifungal stewardship strategies","journal-title":"J Eur Acad Dermatol Venereol","doi-asserted-by":null},{"DOI":"10.1111/jdv.20146","key":"e_1_2_12_4_1","year":"2025","issue":"6","author":"Khan SS","volume":"39","first-page":"1185","unstructured":null,"article-title":"An international survey of recalcitrant and recurrent tinea of the glabrous skin—a potential indicator of antifungal resistance","journal-title":"J Eur Acad Dermatol Venereol","doi-asserted-by":"crossref"},{"DOI":"10.1111/jdv.20752","key":"e_1_2_12_5_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":null,"key":"e_1_2_12_6_1","year":"2014","issue":"4","author":"Mao D","volume":"12","first-page":"226","unstructured":null,"article-title":"Tinea lucidum or dermatophytosis of the stratum lucidum: is the epidermal location of dermatophyte infection evolving?","journal-title":"Skinmed","doi-asserted-by":null},{"DOI":"10.1111/myc.70081","key":"e_1_2_12_7_1","year":"2025","issue":"6","author":"Liu H","volume":"68","first-page":null,"unstructured":null,"article-title":"Biologic therapy and superficial fungal infection risk in moderate‐to‐severe psoriasis: a meta‐analysis","journal-title":"Mycoses","doi-asserted-by":"crossref"},{"DOI":"10.1097/00001432-200404000-00002","key":"e_1_2_12_8_1","year":"2004","issue":"2","author":"Hay RJ","volume":"17","first-page":"77","unstructured":null,"article-title":"Deep dermatophytosis: rare infections or common, but unrecognised, complications of lymphatic spread?","journal-title":"Curr Opin Infect Dis","doi-asserted-by":"crossref"},{"DOI":"10.3390/jof2010004","key":"e_1_2_12_9_1","year":"2015","issue":"1","author":"Rouzaud C","volume":"2","first-page":null,"unstructured":null,"article-title":"Severe dermatophytosis and acquired or innate immunodeficiency: a review","journal-title":"J Fungi","doi-asserted-by":"crossref"},{"DOI":"10.1371/journal.ppat.1012258","key":"e_1_2_12_10_1","year":"2024","issue":"6","author":"Dellière S","volume":"20","first-page":null,"unstructured":null,"article-title":"Current and emerging issues in dermatophyte infections","journal-title":"PLoS Pathog","doi-asserted-by":"crossref"},{"DOI":"10.3390/jof7110929","key":"e_1_2_12_11_1","year":"2021","issue":"11","author":"Castellanos J","volume":"7","first-page":"929","unstructured":null,"article-title":"Unusual inflammatory tinea infections: Majocchi's granuloma and deep/systemic dermatophytosis","journal-title":"J Fungi","doi-asserted-by":"crossref"},{"DOI":"10.1111/myc.13212","key":"e_1_2_12_12_1","year":"2021","issue":"4","author":"Wang R","volume":"64","first-page":"340","unstructured":null,"article-title":"Invasive dermatophyte infection: a systematic review","journal-title":"Mycoses","doi-asserted-by":"crossref"},{"DOI":"10.1007/978-3-030-67421-2_4","key":"e_1_2_12_13_1","year":"2021","issue":null,"author":"Durdu M","volume":null,"first-page":"65","unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":"10.1093/trstmh/traa163","key":"e_1_2_12_14_1","year":"2021","issue":"4","author":"Traxler RM","volume":"115","first-page":"437","unstructured":null,"article-title":"Development of the global Mycetoma working group","journal-title":"Trans R Soc Trop Med Hyg","doi-asserted-by":"crossref"},{"DOI":null,"key":"e_1_2_12_15_1","year":"2025","issue":null,"author":"Veritas Health Innovation","volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":"10.25259/IJDVL_301_20","key":"e_1_2_12_16_1","year":"2021","issue":null,"author":"Verma SB","volume":"87","first-page":"154","unstructured":null,"article-title":"The unprecedented epidemic‐like scenario of dermatophytosis in India: I. Epidemiology, risk factors and clinical features","journal-title":"Indian J Dermatol Venereol Leprol","doi-asserted-by":"crossref"},{"DOI":null,"key":"e_1_2_12_17_1","year":"2019","issue":"3","author":"Akay BN","volume":"60","first-page":"e252","unstructured":null,"article-title":"Deep fungal infection caused by Trichophyton rubrum after heart transplantation: a case report with dermoscopy","journal-title":"Australas J Dermatol","doi-asserted-by":null},{"DOI":"10.1016/j.breast.2005.04.008","key":"e_1_2_12_18_1","year":"2006","issue":"2","author":"Ali SS","volume":"15","first-page":"263","unstructured":null,"article-title":"Bilateral breast enlargement due to Trichophyton rubrum","journal-title":"Breast","doi-asserted-by":"crossref"},{"DOI":"10.1111/j.1365-2133.1974.tb06379.x","key":"e_1_2_12_19_1","year":"1974","issue":"2","author":"Burgoon CF","volume":"90","first-page":"155","unstructured":null,"article-title":"Mycetoma formation in Trichophyton rubrum infection","journal-title":"Br J Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.mycmed.2017.01.001","key":"e_1_2_12_20_1","year":"2017","issue":"2","author":"Boudghene Stambouli O","volume":"27","first-page":"250","unstructured":null,"article-title":"Dermatophytic disease with deficit in CARD9: a new case with a brain impairment","journal-title":"J Mycol Med","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.mycmed.2008.10.004","key":"e_1_2_12_21_1","year":"2009","issue":"1","author":"Bienvenu AL","volume":"19","first-page":"40","unstructured":null,"article-title":"Manifestations cliniques atypiques dues à Trichophyton rubrum chez un patient immunodéprimé","journal-title":"J Mycol Med","doi-asserted-by":"crossref"},{"DOI":"10.1093/mmy/myae001","key":"e_1_2_12_22_1","year":"2024","issue":"2","author":"Bertin C","volume":"62","first-page":"1","unstructured":null,"article-title":"Deep cutaneous mycoses in kidney transplant recipients: diagnostic and therapeutic challenges","journal-title":"Med Mycol","doi-asserted-by":"crossref"},{"DOI":"10.1111/j.1600-0560.2006.00628.x","key":"e_1_2_12_23_1","year":"2007","issue":"5","author":"Berg JC","volume":"34","first-page":"431","unstructured":null,"article-title":"Pseudomycetoma caused by Microsporum canis in an immunosuppressed patient: a case report and review of the literature","journal-title":"J Cutan Pathol","doi-asserted-by":"crossref"},{"DOI":"10.1111/ijd.15294","key":"e_1_2_12_24_1","year":"2021","issue":"1","author":"Benmehidi N","volume":"60","first-page":"e15","unstructured":null,"article-title":"A new case of deep dermatophytic disease with inherited CARD9 deficiency","journal-title":"Int J Dermatol","doi-asserted-by":"crossref"},{"DOI":null,"key":"e_1_2_12_25_1","year":"2019","issue":"1","author":"Dai Y","volume":"19","first-page":"4","unstructured":null,"article-title":"Multiple abscesses in the lower extremities caused by Trichophyton rubrum","journal-title":"BMC Infect Dis","doi-asserted-by":null},{"DOI":"10.1016/j.dsi.2013.11.002","key":"e_1_2_12_26_1","year":"2014","issue":"3","author":"Cheng CY","volume":"32","first-page":"191","unstructured":null,"article-title":"Disseminated deep dermatophytosis caused by Trichophyton rubrum","journal-title":"Dermatol Sin","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.annder.2010.01.006","key":"e_1_2_12_27_1","year":"2010","issue":"3","author":"Cheikhrouhou F","volume":"137","first-page":"208","unstructured":null,"article-title":"Un cas de maladie dermatophytique fatale par abcès rétropharyngé","journal-title":"Ann Dermatol Venereol","doi-asserted-by":"crossref"},{"DOI":"10.1111/ijd.13220","key":"e_1_2_12_28_1","year":"2017","issue":"3","author":"Chai ZT","volume":"56","first-page":"269","unstructured":null,"article-title":"Deep dermal fungal infection in an Asian renal transplant recipient","journal-title":"Int J Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1111/cup.14817","key":"e_1_2_12_29_1","year":"2025","issue":null,"author":"Alkurdi E","volume":"52","first-page":"466","unstructured":null,"article-title":"Invasive Trichophyton rubrum mimicking blastomycosis in an immunocompromised patient","journal-title":"J Cutan Pathol","doi-asserted-by":"crossref"},{"DOI":"10.1046/j.1365-4362.2001.01096.x","key":"e_1_2_12_30_1","year":"2001","issue":"5","author":"Franco RC","volume":"40","first-page":"363","unstructured":null,"article-title":"Deep dermatophytosis in a post transplant recipient","journal-title":"Int J Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1111/cup.14764","key":"e_1_2_12_31_1","year":"2024","issue":"2","author":"Forster AM","volume":"52","first-page":"73","unstructured":null,"article-title":"An unusual, symmetric rash on both forearms in a 94‐year‐old patient a clinicopathological challenge and diagnostic pitfall","journal-title":"J Cutan Pathol","doi-asserted-by":"crossref"},{"DOI":"10.1023/A:1016328001146","key":"e_1_2_12_32_1","year":"2002","issue":"4","author":"Erbagci Z","volume":"154","first-page":"163","unstructured":null,"article-title":"Deep dermatophytoses in association with atopy and diabetes mellitus: Majocchi's granuloma tricophyticum or dermatophytic pseudomycetoma?","journal-title":"Mycopathologia","doi-asserted-by":"crossref"},{"DOI":"10.1111/j.1365-4632.2009.04458.x","key":"e_1_2_12_33_1","year":"2011","issue":"10","author":"Dan P","volume":"50","first-page":"1266","unstructured":null,"article-title":"Invasive cutaneous Trichophyton shoenleinii infection in an immunosuppressed patient","journal-title":"Int J Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.jaad.2014.03.042","key":"e_1_2_12_34_1","year":"2014","issue":"2","author":"Gonzalez Santiago TM","volume":"71","first-page":"293","unstructured":null,"article-title":"Diagnosis of deep cutaneous fungal infections: correlation between skin tissue culture and histopathology","journal-title":"J Am Acad Dermatol","doi-asserted-by":"crossref"},{"DOI":null,"key":"e_1_2_12_35_1","year":"2025","issue":"10","author":"González Rodríguez B","volume":"164","first-page":null,"unstructured":null,"article-title":"Deep dermatophytosis caused by Trichophyton rubrum","journal-title":"Med Clin (Barc)","doi-asserted-by":null},{"DOI":"10.1111/myc.12001","key":"e_1_2_12_36_1","year":"2013","issue":"3","author":"Gönül M","volume":"56","first-page":"361","unstructured":null,"article-title":"Deep Trichophyton rubrum infection presenting with umbilicated papulonodules in a cardiac transplant recipient","journal-title":"Mycoses","doi-asserted-by":"crossref"},{"DOI":"10.1111/j.1439-0507.2006.01324.x","key":"e_1_2_12_37_1","year":"2007","issue":"2","author":"Gong JQ","volume":"50","first-page":"102","unstructured":null,"article-title":"Deep dermatophytosis caused by Trichophyton rubrum: report of two cases","journal-title":"Mycoses","doi-asserted-by":"crossref"},{"DOI":"10.1007/s11046-019-00357-4","key":"e_1_2_12_38_1","year":"2019","issue":"4","author":"Guanziroli E","volume":"184","first-page":"543","unstructured":null,"article-title":"Deep dermatophytosis caused by Trichophyton verrucosum in an immunosuppressed patient: successful outcome with terbinafine","journal-title":"Mycopathologia","doi-asserted-by":"crossref"},{"DOI":"10.1007/s10875-015-0170-4","key":"e_1_2_12_39_1","year":"2015","issue":"5","author":"Grumach AS","volume":"35","first-page":"486","unstructured":null,"article-title":"A homozygous CARD9 mutation in a Brazilian patient with deep dermatophytosis","journal-title":"J Clin Immunol","doi-asserted-by":"crossref"},{"DOI":"10.1007/s10875-016-0255-8","key":"e_1_2_12_40_1","year":"2016","issue":"3","author":"Alves de Medeiros AK","volume":"36","first-page":"204","unstructured":null,"article-title":"Chronic and invasive fungal infections in a family with CARD9 deficiency","journal-title":"J Clin Immunol","doi-asserted-by":"crossref"},{"DOI":"10.1016/0190-9622(95)90270-8","key":"e_1_2_12_41_1","year":"1995","issue":"2","author":"Grossman ME","volume":"33","first-page":"315","unstructured":null,"article-title":"Invasive Trichophyton rubrum infection in the immunocompromised host: report of three cases","journal-title":"J Am Acad Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1007/s40257-017-0309-6","key":"e_1_2_12_42_1","year":"2017","issue":"5","author":"González‐Cantero Á","volume":"18","first-page":"709","unstructured":null,"article-title":"Comment on: “A unique clinicopathological manifestation of fungal infection: a case series of deep dermatophytosis in immunosuppressed patients”","journal-title":"Am J Clin Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1001/archderm.1983.01650300036013","key":"e_1_2_12_43_1","year":"1983","issue":"6","author":"Hironaga M","volume":"119","first-page":"482","unstructured":null,"article-title":"Trichophyton mentagrophytes granulomas","journal-title":"Arch Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1111/j.1346-8138.2004.tb00612.x","key":"e_1_2_12_44_1","year":"2004","issue":"10","author":"Kwon KS","volume":"31","first-page":"839","unstructured":null,"article-title":"Widespread and invasive Trichophyton rubrum infection mimicking Kaposi's sarcoma in a patient with AIDS","journal-title":"J Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.jaad.2005.03.058","key":"e_1_2_12_45_1","year":"2006","issue":"2","author":"Kobayashi M","volume":"54","first-page":"11","unstructured":null,"article-title":"Tinea profunda cysticum caused by Trichophyton rubrum","journal-title":"J Am Acad Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1128/jcm.34.2.460-462.1996","key":"e_1_2_12_46_1","year":"1996","issue":"2","author":"King D","volume":"34","first-page":"460","unstructured":null,"article-title":"Primary invasive cutaneous Microsporum canis infections in immunocompromised patients","journal-title":"J Clin Microbiol","doi-asserted-by":"crossref"},{"DOI":null,"key":"e_1_2_12_47_1","year":"2016","issue":"1","author":"Kim SH","volume":"16","first-page":"1","unstructured":null,"article-title":"Dermatophyte abscesses caused by Trichophyton rubrum in a patient without pre‐existing superficial dermatophytosis: a case report","journal-title":"BMC Infect Dis","doi-asserted-by":null},{"DOI":"10.1007/s40257-017-0276-y","key":"e_1_2_12_48_1","year":"2017","issue":"5","author":"Kershenovich R","volume":"18","first-page":"697","unstructured":null,"article-title":"A unique clinicopathological manifestation of fungal infection: a case series of deep dermatophytosis in immunosuppressed patients","journal-title":"Am J Clin Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1001/jamadermatol.2014.2154","key":"e_1_2_12_49_1","year":"2015","issue":"2","author":"Jachiet M","volume":"151","first-page":"192","unstructured":null,"article-title":"Posaconazole treatment of extensive skin and nail dermatophytosis due to autosomal recessive deficiency of CARD9","journal-title":"JAMA Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1111/myc.12317","key":"e_1_2_12_50_1","year":"2015","issue":"5","author":"Inaoki M","volume":"58","first-page":"318","unstructured":null,"article-title":"Case of dermatophyte abscess caused by Trichophyton rubrum: a case report and review of the literature","journal-title":"Mycoses","doi-asserted-by":"crossref"},{"DOI":"10.1111/1346-8138.16995","key":"e_1_2_12_51_1","year":"2024","issue":"2","author":"Ansai O","volume":"51","first-page":"294","unstructured":null,"article-title":"Deep dermatophytosis caused by Trichophyton rubrum in an elderly patient with CARD9 deficiency: a case report and literature review","journal-title":"J Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1016/S1473-3099(19)30551-1","key":"e_1_2_12_52_1","year":"2019","issue":"12","author":"Huang C","volume":"19","first-page":"1380","unstructured":null,"article-title":"Deep dermatophytosis caused by Trichophyton rubrum","journal-title":"Lancet Infect Dis","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.abd.2021.08.018","key":"e_1_2_12_53_1","year":"2023","issue":"4","author":"Li W","volume":"98","first-page":"544","unstructured":null,"article-title":"Generalized nodular tinea profunda in an immunosuppressed patient caused by Trichophyton rubrum","journal-title":"An Bras Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1111/j.1365-4362.1988.tb01269.x","key":"e_1_2_12_54_1","year":"1988","issue":"10","author":"Lestringant GG","volume":"27","first-page":"707","unstructured":null,"article-title":"Deep dermatophytosis to Trichophyton rubrum and T. verrucosum in an immunosuppressed patient","journal-title":"Int J Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.2310/7750.2007.00009","key":"e_1_2_12_55_1","year":"2007","issue":"2","author":"Lowther AL","volume":"11","first-page":"84","unstructured":null,"article-title":"Invasive Trichophyton rubrum infection occurring with infliximab and long‐term prednisone treatment","journal-title":"J Cutan Med Surg","doi-asserted-by":"crossref"},{"DOI":null,"key":"e_1_2_12_56_1","year":"2024","issue":"1","author":"Loginus W","volume":"47","first-page":"2024","unstructured":null,"article-title":"Multiple facial deep dermatophytosis caused by Trichophyton rubrum in an immunocompromised patient","journal-title":"Am J Dermatopathol","doi-asserted-by":null},{"DOI":"10.1111/j.1600-0560.2009.01355.x","key":"e_1_2_12_57_1","year":"2010","issue":"11","author":"Lillis JV","volume":"37","first-page":"1168","unstructured":null,"article-title":"Disseminated dermal Trichophyton rubrum infection – an expression of dermatophyte dimorphism?","journal-title":"J Cutan Pathol","doi-asserted-by":"crossref"},{"DOI":"10.1056/NEJMoa1208487","key":"e_1_2_12_58_1","year":"2013","issue":"18","author":"Lanternier F","volume":"369","first-page":"1704","unstructured":null,"article-title":"Deep dermatophytosis and inherited CARD9 deficiency","journal-title":"N Engl J Med","doi-asserted-by":"crossref"},{"DOI":"10.1111/j.1365-2230.1987.tb02518.x","key":"e_1_2_12_59_1","year":"1987","issue":"5","author":"Mayou SC","volume":"12","first-page":"385","unstructured":null,"article-title":"Deep (subcutaneous) dermatophyte infection presenting with unilateral lymphoedema","journal-title":"Clin Exp Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.2340/00015555-1452","key":"e_1_2_12_60_1","year":"2013","issue":"3","author":"Matsuzaki Y","volume":"93","first-page":"358","unstructured":null,"article-title":"Deep pseudocystic dermatophytosis caused by Trichophyton rubrum in a patient with myasthenia gravis","journal-title":"Acta Derm Venereol","doi-asserted-by":"crossref"},{"DOI":"10.1001/archderm.1957.01550160069008","key":"e_1_2_12_61_1","year":"1957","issue":"4","author":"Mullins J","volume":"75","first-page":"543","unstructured":null,"article-title":"Deep‐seated pustular Trichophyton rubrum","journal-title":"AMA Arch Derm","doi-asserted-by":"crossref"},{"DOI":"10.1001/jamadermatol.2013.2129a","key":"e_1_2_12_62_1","year":"2013","issue":"4","author":"Azib S","volume":"149","first-page":"475","unstructured":null,"article-title":"Nodules on the legs in a renal transplant recipient. Deep dermal dermatophytosis caused by Trichophyton rubrum","journal-title":"JAMA Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1111/tid.13794","key":"e_1_2_12_63_1","year":"2022","issue":"2","author":"Mularoni A","volume":"24","first-page":"1","unstructured":null,"article-title":"Invasive Trichophyton infection in a liver transplant recipient","journal-title":"Transpl Infect Dis","doi-asserted-by":"crossref"},{"DOI":null,"key":"e_1_2_12_64_1","year":"2021","issue":"3","author":"Mehwald‐Göke M","volume":"47","first-page":"96","unstructured":null,"article-title":"Deep dermatophytosis combined with tinea corporis","journal-title":"Aktuelle Derm","doi-asserted-by":null},{"DOI":"10.1097/DAD.0b013e31829ac0fa","key":"e_1_2_12_65_1","year":"2014","issue":"3","author":"Mantovani L","volume":"36","first-page":"263","unstructured":null,"article-title":"A verrucous and ulcerated lesion of the leg: answer","journal-title":"Am J Dermatopathol","doi-asserted-by":"crossref"},{"DOI":"10.1111/cup.13574","key":"e_1_2_12_66_1","year":"2020","issue":"2","author":"Nazarian RM","volume":"47","first-page":"166","unstructured":null,"article-title":"Novel CARD9 mutation in a patient with chronic invasive dermatophyte infection (tinea profunda)","journal-title":"J Cutan Pathol","doi-asserted-by":"crossref"},{"DOI":"10.1111/1346-8138.13669","key":"e_1_2_12_67_1","year":"2017","issue":"5","author":"Namba HD","volume":"44","first-page":"e97","unstructured":null,"article-title":"Eumycetoma caused by Trichophyton species successfully treated with terbinafine and surgery","journal-title":"J Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1111/tid.12799","key":"e_1_2_12_68_1","year":"2018","issue":"1","author":"Rouzaud C","volume":"20","first-page":"1","unstructured":null,"article-title":"Severe dermatophytosis in solid organ transplant recipients: a French retrospective series and literature review","journal-title":"Transpl Infect Dis","doi-asserted-by":"crossref"},{"DOI":"10.1007/s10875-019-00662-z","key":"e_1_2_12_69_1","year":"2019","issue":"5","author":"Queiroz‐Telles F","volume":"39","first-page":"462","unstructured":null,"article-title":"Successful allogenic stem cell transplantation in patients with inherited CARD9 deficiency","journal-title":"J Clin Immunol","doi-asserted-by":"crossref"},{"DOI":"10.1111/j.1365-2133.2006.07371.x","key":"e_1_2_12_70_1","year":"2006","issue":"3","author":"Petrov I","volume":"155","first-page":"628","unstructured":null,"article-title":"Disseminated dermatophytic pseudomycetomas arising in an immunocompromised patient","journal-title":"Br J Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.mycmed.2023.101456","key":"e_1_2_12_71_1","year":"2024","issue":"1","author":"Ouaaziz I","volume":"34","first-page":"2","unstructured":null,"article-title":"Deep‐seated dermatophytosis caused by Trichophyton rubrum in patient with Becker muscular dystrophy","journal-title":"J Med Mycol","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.mmcr.2018.03.001","key":"e_1_2_12_72_1","year":"2018","issue":null,"author":"Okata‐Karigane U","volume":"21","first-page":"16","unstructured":null,"article-title":"Subcutaneous abscesses caused by Trichophyton rubrum in the unilateral groin of an immunocompromised patient: a case report","journal-title":"Med Mycol Case Rep","doi-asserted-by":"crossref"},{"DOI":null,"key":"e_1_2_12_73_1","year":"2024","issue":"3","author":"Benchetrit A","volume":"56","first-page":"217","unstructured":null,"article-title":"Microsporum canis pseudomycetoma and disseminated Mycobacterium genavense infection in an HIV/AIDS patient, an unusual combination","journal-title":"Rev Argent Microbiol","doi-asserted-by":null},{"DOI":"10.1016/0002-9343(87)90078-7","key":"e_1_2_12_74_1","year":"1987","issue":"2","author":"Novick NL","volume":"82","first-page":"321","unstructured":null,"article-title":"Invasive Trichophyton rubrum infection in an immunocompromised host. Case report and review of the literature","journal-title":"Am J Med","doi-asserted-by":"crossref"},{"DOI":"10.1128/JCM.41.11.5298-5301.2003","key":"e_1_2_12_75_1","year":"2003","issue":"11","author":"Nir‐Paz R","volume":"41","first-page":"5298","unstructured":null,"article-title":"Deep infection by Trichophyton rubrum in an immunocompromised patient","journal-title":"J Clin Microbiol","doi-asserted-by":"crossref"},{"DOI":"10.1186/s12879-023-08752-5","key":"e_1_2_12_76_1","year":"2023","issue":"1","author":"Si H","volume":"23","first-page":"789","unstructured":null,"article-title":"Erythroderma combined with deeper dermal dermatophytosis due to Trichophyton rubrum in a patient with myasthenia gravis: first case report and literature review","journal-title":"BMC Infect Dis","doi-asserted-by":"crossref"},{"DOI":"10.1111/j.1365-2133.1979.tb05605.x","key":"e_1_2_12_77_1","year":"1979","issue":"2","author":"Swart E","volume":"101","first-page":"177","unstructured":null,"article-title":"Trichophyton violaceum abscesses","journal-title":"Br J Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1111/ijd.17803","key":"e_1_2_12_78_1","year":"2025","issue":null,"author":"Somasundaram A","volume":"64","first-page":"2088","unstructured":null,"article-title":"Deep dermatophytosis in an immunocompromised patient","journal-title":"Int J Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.jdcr.2021.01.017","key":"e_1_2_12_79_1","year":"2021","issue":null,"author":"Snyder A","volume":"9","first-page":"86","unstructured":null,"article-title":"Cryptic deep dermatophytosis in a renal transplant recipient with hidradenitis suppurativa","journal-title":"JAAD Case Rep","doi-asserted-by":"crossref"},{"DOI":"10.1046/j.1365-2133.2001.04331.x","key":"e_1_2_12_80_1","year":"2001","issue":"2","author":"Smith KJ","volume":"145","first-page":"344","unstructured":null,"article-title":"Trichophyton rubrum showing deep dermal invasion directly from the epidermis in immunosuppressed patients","journal-title":"Br J Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1111/bjd.15781","key":"e_1_2_12_81_1","year":"2018","issue":"3","author":"Simpson JK","volume":"179","first-page":"750","unstructured":null,"article-title":"Invasive dermatophyte infection with Trichophyton interdigitale is associated with prurigo‐induced pseudoperforation and a signal transducer and activator of transcription 3 mutation","journal-title":"Br J Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.abd.2021.05.014","key":"e_1_2_12_82_1","year":"2022","issue":"2","author":"Silva L","volume":"97","first-page":"223","unstructured":null,"article-title":"Deep dermatophytosis caused by Trichophyton rubrum in immunocompromised patients","journal-title":"An Bras Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1002/dc.25169","key":"e_1_2_12_83_1","year":"2023","issue":"8","author":"Shah S","volume":"51","first-page":"E239","unstructured":null,"article-title":"Cytomorphological findings of Trichophyton rubrum infection in an elderly hypertensive woman","journal-title":"Diagn Cytopathol","doi-asserted-by":"crossref"},{"DOI":null,"key":"e_1_2_12_84_1","year":"2020","issue":"10","author":"Belda Junior W","volume":"62","first-page":"788","unstructured":null,"article-title":"Atypical clinical presentation of an Arthroderma gypseum infection in a renal transplant recipient","journal-title":"Rev Inst Med Trop Sao Paulo","doi-asserted-by":null},{"DOI":"10.17966/JMI.2022.27.4.85","key":"e_1_2_12_85_1","year":"2022","issue":"4","author":"Seol JE","volume":"27","first-page":"85","unstructured":null,"article-title":"Deep dermatophytosis presented as multiple exophytic masses caused by Trichophyton rubrum in immunocompromised patient with rheumatoid arthritis: A case report","journal-title":"J Mycol Infect","doi-asserted-by":"crossref"},{"DOI":"10.1023/A:1006984116046","key":"e_1_2_12_86_1","year":"1998","issue":"1","author":"Sentamilselvi G","volume":"142","first-page":"9","unstructured":null,"article-title":"Deep dermatophytosis caused by Trichophyton rubrum – a case report","journal-title":"Mycopathologia","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.jaad.2004.05.008","key":"e_1_2_12_87_1","year":"2004","issue":"5","author":"Seçkin D","volume":"51","first-page":"S173","unstructured":null,"article-title":"Deep dermatophytosis caused by Trichophyton rubrum with concomitant disseminated nocardiosis in a renal transplant recipient","journal-title":"J Am Acad Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1007/s11046-020-00520-2","key":"e_1_2_12_88_1","year":"2021","issue":"3","author":"Sang J","volume":"186","first-page":"461","unstructured":null,"article-title":"Deep dermatophytosis caused by Trichophyton rubrum","journal-title":"Mycopathologia","doi-asserted-by":"crossref"},{"DOI":"10.1007/s11046-017-0120-1","key":"e_1_2_12_89_1","year":"2017","issue":"7","author":"Su HA","volume":"182","first-page":"715","unstructured":null,"article-title":"Deep dermatophytosis caused by zoophilic strain of Trichophyton interdigitale with successful treatment of itraconazole","journal-title":"Mycopathologia","doi-asserted-by":"crossref"},{"DOI":"10.1007/s11046-016-0099-z","key":"e_1_2_12_90_1","year":"2017","issue":"5","author":"Su H","volume":"182","first-page":"549","unstructured":null,"article-title":"Trichophyton rubrum infection characterized by Majocchi's granuloma and deeper dermatophytosis: case report and review of published literature","journal-title":"Mycopathologia","doi-asserted-by":"crossref"},{"DOI":"10.1111/tid.13830","key":"e_1_2_12_91_1","year":"2022","issue":"3","author":"Sriram N","volume":"24","first-page":"22","unstructured":null,"article-title":"Trichophyton onychomycosis and deep dermatophytosis in a post‐heart transplant patient","journal-title":"Transpl Infect Dis","doi-asserted-by":"crossref"},{"DOI":"10.1016/S0190-9622(98)70396-2","key":"e_1_2_12_92_1","year":"1998","issue":"2","author":"Squeo RF","volume":"39","first-page":"379","unstructured":null,"article-title":"Invasive Trichophyton rubrum resembling blastomycosis infection in the immunocompromised host","journal-title":"J Am Acad Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1080/22221751.2023.2208685","key":"e_1_2_12_93_1","year":"2023","issue":"1","author":"Song Y","volume":"12","first-page":null,"unstructured":null,"article-title":"Fatal dermatophytic pseudomycetoma in a patient with non‐HIV CD4 lymphocytopenia","journal-title":"Emerg Microbes Infect","doi-asserted-by":"crossref"},{"DOI":"10.1046/j.1365-2133.1999.02985.x","key":"e_1_2_12_94_1","year":"1999","issue":"2","author":"Sommer S","volume":"141","first-page":"323","unstructured":null,"article-title":"Microbiological and molecular diagnosis of deep localized cutaneous infection with Trichophyton mentagrophytes","journal-title":"Br J Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1159/000325759","key":"e_1_2_12_95_1","year":"2007","issue":"3","author":"Barboza‐Quintana O","volume":"51","first-page":"424","unstructured":null,"article-title":"Pseudomycetoma for Microsporum canis: report of a case diagnosed by fine needle aspiration biopsy","journal-title":"Acta Cytol","doi-asserted-by":"crossref"},{"DOI":"10.1016/S0190-9622(96)90298-4","key":"e_1_2_12_96_1","year":"1996","issue":"6","author":"Tsang P","volume":"34","first-page":"1090","unstructured":null,"article-title":"Deep dermatophytosis caused by Trichophyton rubrum in a patient with AIDS","journal-title":"J Am Acad Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1111/j.1365-2230.2005.01839.x","key":"e_1_2_12_97_1","year":"2005","issue":"5","author":"Tejasvi T","volume":"30","first-page":"506","unstructured":null,"article-title":"Invasive dermatophytosis with lymph node involvement in an immunocompetent patient","journal-title":"Clin Exp Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1001/archderm.140.5.624","key":"e_1_2_12_98_1","year":"2004","issue":"5","author":"Tateishi Y","volume":"140","first-page":"624","unstructured":null,"article-title":"Severe generalized deep dermatophytosis due to Trichophyton rubrum (trichophytic granuloma) in a patient with atopic dermatitis","journal-title":"Arch Dermatol","doi-asserted-by":"crossref"},{"DOI":null,"key":"e_1_2_12_99_1","year":"2022","issue":null,"author":"Tan J","volume":"13","first-page":"1","unstructured":null,"article-title":"Case report: severe deep ulcer on the left abdomen mimicking mycosis fungoides caused by Trichophyton tonsurans in a patient with novel CARD9 mutation","journal-title":"Front Immunol","doi-asserted-by":null},{"DOI":"10.1111/cup.12987","key":"e_1_2_12_100_1","year":"2017","issue":"9","author":"Talebi‐Liasi F","volume":"44","first-page":"798","unstructured":null,"article-title":"Invasive Trichophyton rubrum mimicking blastomycosis in a patient with solid organ transplant","journal-title":"J Cutan Pathol","doi-asserted-by":"crossref"},{"DOI":"10.1093/ofid/ofaa281","key":"e_1_2_12_101_1","year":"2020","issue":"7","author":"Trottier CA","volume":"7","first-page":"1","unstructured":null,"article-title":"Beyond the superficial: disseminated Trichophyton rubrum infection in a kidney transplant recipient","journal-title":"Open Forum Infect Dis","doi-asserted-by":"crossref"},{"DOI":null,"key":"e_1_2_12_102_1","year":"2012","issue":"2","author":"Trabelsi S","volume":"90","first-page":"196","unstructured":null,"article-title":"First case of subcutaneous dermatomycoses in a Tunisian renal transplant patient","journal-title":"Tunis Med","doi-asserted-by":null},{"DOI":"10.3314/mmj.17-00003","key":"e_1_2_12_103_1","year":"2017","issue":"2","author":"Toyoki M","volume":"58","first-page":"E63","unstructured":null,"article-title":"A giant dermatophyte abscess caused by Trichophyton rubrum in an immunocompromised patient","journal-title":"Med Mycol J","doi-asserted-by":"crossref"},{"DOI":"10.3389/fmed.2019.00097","key":"e_1_2_12_104_1","year":"2019","issue":null,"author":"Toussaint F","volume":"6","first-page":"1","unstructured":null,"article-title":"Multiple dermal abscesses by Trichophyton rubrum in an immunocompromised patient","journal-title":"Front Med","doi-asserted-by":"crossref"},{"DOI":null,"key":"e_1_2_12_105_1","year":"2021","issue":"3","author":"Teo TSP","volume":"23","first-page":"1","unstructured":null,"article-title":"Mycetoma caused by Microsporum canis in a patient with renal transplant: a case report and review of the literature","journal-title":"Transpl Infect Dis","doi-asserted-by":null},{"DOI":"10.1001/archinte.1984.00350150227044","key":"e_1_2_12_106_1","year":"1984","issue":"3","author":"Baker RL","volume":"144","first-page":"615","unstructured":null,"article-title":"Successful use of ketoconazole for invasive cutaneous: Trichophyton rubrum infection","journal-title":"Arch Intern Med","doi-asserted-by":"crossref"},{"DOI":"10.1007/s11046-020-00487-0","key":"e_1_2_12_107_1","year":"2020","issue":"6","author":"Wang X","volume":"185","first-page":"1041","unstructured":null,"article-title":"CARD9 deficiency in a Chinese man with cutaneous mucormycosis, recurrent deep dermatophytosis and a review of the literature","journal-title":"Mycopathologia","doi-asserted-by":"crossref"},{"DOI":null,"key":"e_1_2_12_108_1","year":"2021","issue":"32","author":"Vu LT","volume":"18","first-page":null,"unstructured":null,"article-title":"The first case of Trichophyton spp. pneumonia reported in Vietnam","journal-title":"Respir Med Case Rep","doi-asserted-by":null},{"DOI":"10.1007/s11046-022-00655-4","key":"e_1_2_12_109_1","year":"2022","issue":"5","author":"Yun SK","volume":"187","first-page":"611","unstructured":null,"article-title":"Deeper dermal dermatophytosis by Trichophyton rubrum infection mimicking Kaposi sarcoma","journal-title":"Mycopathologia","doi-asserted-by":"crossref"},{"DOI":"10.1007/s11046-022-00633-w","key":"e_1_2_12_110_1","year":"2022","issue":"2","author":"Xia XJ","volume":"187","first-page":"189","unstructured":null,"article-title":"Bedside diagnosis for disseminated deep dermatophytosis: a case series study","journal-title":"Mycopathologia","doi-asserted-by":"crossref"},{"DOI":null,"key":"e_1_2_12_111_1","year":"2013","issue":"5","author":"Wu LC","volume":"176","first-page":"457","unstructured":null,"article-title":"Extensive deep dermatophytosis cause by Trichophyton rubrum in a patient with liver cirrhosis and chronic renal failure","journal-title":"Mycopathologia","doi-asserted-by":null},{"DOI":"10.1093/ajcp/73.3.447","key":"e_1_2_12_112_1","year":"1980","issue":"3","author":"West BC","volume":"73","first-page":"447","unstructured":null,"article-title":"Mycetoma caused by Microsporum audouinii. First reported case","journal-title":"Am J Clin Pathol","doi-asserted-by":"crossref"},{"DOI":null,"key":"e_1_2_12_113_1","year":"2023","issue":"6","author":"Chanyachailert P","volume":"9","first-page":null,"unstructured":null,"article-title":"Cutaneous fungal infections caused by dermatophytes and non‐dermatophytes: an updated comprehensive review of epidemiology, clinical presentations, and diagnostic testing","journal-title":"J Fungi (Basel, Switzerland)","doi-asserted-by":null},{"DOI":"10.1111/j.1365-2133.2005.06838.x","key":"e_1_2_12_114_1","year":"2005","issue":"5","author":"Baran R","volume":"153","first-page":"1023","unstructured":null,"article-title":"Could proximal white subungual onychomycosis be a complication of systemic spread? The lessons to be learned from Maladie Dermatophytique and other deep infections","journal-title":"Br J Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.cmi.2022.06.031","key":"e_1_2_12_115_1","year":"2022","issue":"11","author":"Cifaldi C","volume":"28","first-page":"1435","unstructured":null,"article-title":"Main human inborn errors of immunity leading to fungal infections","journal-title":"Clin Microbiol Infect","doi-asserted-by":"crossref"},{"DOI":"10.3389/fimmu.2023.1285887","key":"e_1_2_12_116_1","year":"2023","issue":null,"author":"Deng R","volume":"14","first-page":null,"unstructured":null,"article-title":"Dermatophyte infection: from fungal pathogenicity to host immune responses","journal-title":"Front Immunol","doi-asserted-by":"crossref"},{"DOI":"10.1128/CMR.00035-19","key":"e_1_2_12_117_1","year":"2020","issue":"3","author":"Davis JS","volume":"33","first-page":null,"unstructured":null,"article-title":"Infectious complications of biological and small molecule targeted immunomodulatory therapies","journal-title":"Clin Microbiol Rev","doi-asserted-by":"crossref"},{"DOI":"10.1111/j.1365-2133.1993.tb03342.x","key":"e_1_2_12_118_1","year":"1993","issue":"6","author":"Chen AW","volume":"129","first-page":"729","unstructured":null,"article-title":"Dermatophyte pseudomycetoma: a case report","journal-title":"Br J Dermatol","doi-asserted-by":"crossref"},{"DOI":null,"key":"e_1_2_12_119_1","year":"1983","issue":"1","author":"Rinaldi MG","volume":"81","first-page":"41","unstructured":null,"article-title":"Mycetoma or pseudomycetoma? A distinctive mycosis caused by dermatophytes","journal-title":"Mycopathologia","doi-asserted-by":null},{"DOI":"10.1093/bjd/ljad070","key":"e_1_2_12_120_1","year":"2023","issue":"1","author":"Gupta AK","volume":"189","first-page":"12","unstructured":null,"article-title":"Relative impact of traditional vs. newer oral antifungals for dermatophyte toenail onychomycosis: a network meta‐analysis study","journal-title":"Br J Dermatol","doi-asserted-by":"crossref"},{"DOI":"10.1111/jdv.16394","key":"e_1_2_12_121_1","year":"2020","issue":"9","author":"Gupta AK","volume":"34","first-page":"1972","unstructured":null,"article-title":"Onychomycosis: a review","journal-title":"J Eur Acad Dermatol Venereol","doi-asserted-by":"crossref"},{"DOI":"10.1093/infdis/jiaa394","key":"e_1_2_12_122_1","year":"2020","issue":"3","author":"Johnson MD","volume":"222","first-page":"S175","unstructured":null,"article-title":"Core recommendations for antifungal stewardship: a statement of the mycoses study group education and research consortium","journal-title":"J Infect Dis","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.jiac.2024.10.003","key":"e_1_2_12_123_1","year":"2025","issue":"2","author":"Hamada Y","volume":"31","first-page":null,"unstructured":null,"article-title":"Therapeutic drug monitoring of azole antifungal agents","journal-title":"J Infect Chemother","doi-asserted-by":"crossref"},{"DOI":"10.4103/idoj.IDOJ_103_17","key":"e_1_2_12_124_1","year":"2018","issue":"2","author":"Sinha S","volume":"9","first-page":"120","unstructured":null,"article-title":"Antifungal efficacy of amphotericin B against dermatophytes and its relevance in recalcitrant dermatophytoses: a commentary","journal-title":"Indian Dermatol Online J","doi-asserted-by":"crossref"}],"short-title":[],"update-policy":"https://doi.org/10.1002/crossmark_policy","alternative-id":["10.1111/jdv.70115"],"article-number":"jdv.70115","content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"original-title":[],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"reference-count":123,"published-online":{"date-time":null,"timestamp":null,"date-parts":[[2025,10,17]]},"references-count":123,"short-container-title":["Acad Dermatol Venereol"],"is-referenced-by-count":0},"unpaywall":{"doi":"10.1111/jdv.70115","is_oa":true,"title":"Deep and disseminated dermatophytosis in immunocompromised populations—A systematic review","updated":"2025-10-19T00:05:06+00:00","published_date":"2025-10-17","best_oa_location":{"url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.70115","pmh_id":null,"url_for_pdf":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.70115","url_for_landing_page":"https://doi.org/10.1111/jdv.70115"}}},"created_at":"2025-10-29T09:27:25.374Z","updated_at":"2025-10-29T09:27:25.374Z","tags":[{"paper_doi":"10.1111/jdv.70115","tag_type":"age_group","value":"mixed","value_numeric":null},{"paper_doi":"10.1111/jdv.70115","tag_type":"category","value":"Dermatology","value_numeric":null},{"paper_doi":"10.1111/jdv.70115","tag_type":"condition","value":"Deep Dermatophytosis","value_numeric":null},{"paper_doi":"10.1111/jdv.70115","tag_type":"condition","value":"Disseminated Dermatophytosis","value_numeric":null},{"paper_doi":"10.1111/jdv.70115","tag_type":"generic","value":"amphotericin B","value_numeric":null},{"paper_doi":"10.1111/jdv.70115","tag_type":"generic","value":"fluconazole","value_numeric":null},{"paper_doi":"10.1111/jdv.70115","tag_type":"generic","value":"griseofulvin","value_numeric":null},{"paper_doi":"10.1111/jdv.70115","tag_type":"generic","value":"itraconazole","value_numeric":null},{"paper_doi":"10.1111/jdv.70115","tag_type":"generic","value":"posaconazole","value_numeric":null},{"paper_doi":"10.1111/jdv.70115","tag_type":"generic","value":"terbinafine","value_numeric":null},{"paper_doi":"10.1111/jdv.70115","tag_type":"generic","value":"voriconazole","value_numeric":null},{"paper_doi":"10.1111/jdv.70115","tag_type":"impact_flag","value":"limited_evidence","value_numeric":null},{"paper_doi":"10.1111/jdv.70115","tag_type":"modality","value":"Allylamine","value_numeric":null},{"paper_doi":"10.1111/jdv.70115","tag_type":"modality","value":"Polyene Antifungal","value_numeric":null},{"paper_doi":"10.1111/jdv.70115","tag_type":"modality","value":"Triazole Antifungal","value_numeric":null},{"paper_doi":"10.1111/jdv.70115","tag_type":"sample_size","value":"n=134","value_numeric":134},{"paper_doi":"10.1111/jdv.70115","tag_type":"sex","value":"mixed","value_numeric":null},{"paper_doi":"10.1111/jdv.70115","tag_type":"study_design","value":"Systematic Review","value_numeric":null},{"paper_doi":"10.1111/jdv.70115","tag_type":"warning","value":"Findings synthesize heterogeneous case reports and small series; effect estimates are descriptive and non-comparative.","value_numeric":null},{"paper_doi":"10.1111/jdv.70115","tag_type":"warning","value":"The review excludes Majocchi's granuloma; ensure diagnostic criteria align when applying these data.","value_numeric":null},{"paper_doi":"10.1111/jdv.70115","tag_type":"warning","value":"Treatment response rates reflect reported outcomes and may be influenced by reporting bias and variable follow-up.","value_numeric":null}],"summaries":{"what_studied":"A systematic review (search June 2025) of histopathology- and culture-confirmed deep dermatophytosis of glabrous skin, excluding Majocchi's granuloma; 96 studies from 1954–2025 describing 134 patients.","key_result":"Median age was 51 years (IQR 22); 70.1% (94/134) were male, and Trichophyton rubrum was most frequent. Dissemination occurred in 24/134 patients (lymph node involvement confirmed in 15), with bone (5 cases) and brain abscesses (4 cases) reported; among therapies, improvement was reported with terbinafine in 64.8% (35/54), itraconazole in 46.5% (33/71), posaconazole in 58.8% (10/17), and voriconazole in 38.5% (5/13).","limitations":"Most included reports were case reports or small series, creating publication bias; antifungal susceptibility testing and therapeutic drug monitoring data were sparse, and some treatment data were incompletely reported.","practice_takeaway":"In immunocompromised patients with atypical nodules, ulcers, abscesses, or lymphadenopathy, obtain histopathology and culture to diagnose deep dermatophytosis and treat concomitant superficial tinea to reduce autoinoculation risk. Oral terbinafine or itraconazole are commonly used; if newer triazoles are needed, follow antifungal stewardship with therapeutic drug monitoring and watch for drug–drug interactions."}}],"initialOffset":3,"fetchConfig":{"kind":"tags","tags":[{"tag_type":"generic","value":"posaconazole"}]},"breadcrumbItems":[{"name":"Home","href":"/"},{"name":"Research Hub","href":"/hub"},{"name":"Generics","href":"/hub/tag/generic"},{"name":"posaconazole"}],"hrefConfig":{"basePath":"/hub/papers","webViewQueryParams":{"hub_ctx":"tag","hub_tag_type":"generic","hub_tag_value":"posaconazole"}}}]]

Papers